<HTML>
<HEAD>
<STYLE TYPE="text/css"><!--
.c0 { text-align: center; }
.c1 { text-align: center; margin-top: 0em; margin-bottom: 0em; }
.c2 { font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: normal; color: #000000; text-decoration: none; }
.c3 { text-align: center; margin-left: 13%; margin-right: 13%; }
.c4 { font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: bold; color: #000000; text-decoration: none; }
.c5 { text-align: left; }
.c6 { text-align: left; margin-top: 0em; margin-bottom: 0em; }
.c7 { border-collapse: collapse; table-layout: auto; width:100%; }
.c8 { width: 216pt; }
.c9 { width: 252pt; }
.c10 { text-align: left; padding-left: 2pt; vertical-align: top; padding-right: 2pt; }
.c11 { width: 78pt; }
.c12 { text-align: right; padding-left: 2pt; vertical-align: top; padding-right: 2pt; }
.c13 { text-align: right; margin-top: 0em; margin-bottom: 0em; }
.c14 { width: 126pt; }
.c15 { page-break-before: always; }
--></STYLE>
<!-- LXNComment 2827:562830989 -->
<TITLE>&nbsp;</TITLE>
<META TOPIC="null" DOCUMENTS="122" UPDATED="Monday, May 23, 2016  20:07:24 EST" /></HEAD>
<BODY>
<A NAME="DOC_ID_0_0"></A><!-- Hide XML section from browser
<DOC NUMBER=1>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">1 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2016 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Monsanto Co.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Monsanto Co.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">May 20, 2016</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">May 18, 2016</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">863668</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Public Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Amendment Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 18, 2016</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Attitude:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Neutral</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG submitted a non-binding proposal to acquire Monsanto Co, which is reportedly valued for US$43 billion. The transaction is subject to due diligence, regulatory approvals and other conditions. The Board of Directors of Monsanto is reviewing the proposal. On May 12, 2016, it was reported that Bayer AG has held preliminary talks internally and with advisers to acquire Monsanto Co, which is valued for around US$43 billion. The two companies were already said to be discussing a possible combination back in March. Monsanto Co is located in St. Louis, Missouri, United States and engages in the distribution of agricultural.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$43,000,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">29.944</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">-41.992</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$43,000,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$52,028,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$43,000,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Monsanto Co.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">New York Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Engages in the distribution of agricultural products to farmers</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">02/29/2016</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">13,668.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1,873.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1,436.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">718.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">443.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">02/29/2016</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">13,668.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1,873.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1,436.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">718.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">443.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBITDA</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">17.148</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBIT</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">22.465</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$19,413,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,050,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Long Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,083,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Long-Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$7,945,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$-1,024,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$-2.345</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">436,736,829</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3.288</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$87</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$90.340</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$97.720</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$-2.345</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$113.755</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$114.126</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$108.542</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Monsanto Co.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">800 North Lindbergh Boulevard, St. Louis, MO 63167 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.314.694.1000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Stephanie Rach, Pacific Group</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MON</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">61166W10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5191 - Farm supplies </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Morgan Stanley &amp; Co. LLC</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ducera Partners LLC</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Wachtell, Lipton, Rosen &amp; Katz</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">May 23, 2016</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_1"></A><!-- Hide XML section from browser
<DOC NUMBER=2>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">2 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2016 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Syngenta AG /Mikado Brand Sulcotrione Herbicide Business/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Syngenta AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">May 14, 2016</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">February 1, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">February 1, 2001</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">138935</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">February 1, 2001</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, Leverkusen, Nordrhein-Westfalen (North Rhine-Westphalia), Germany, the research based company with major businesses in health care, agriculture, polymers and specialty chemicals, acquired the Mikado Brand sulcotrione herbicide business of Syngenta AG for CHF172.6 million (US$106 million) in cash. Sulcotrione, marketed as Mikado brand, is a foliar-applied post-emergence herbicide from triketone class of compounds. The products major usage is in corn (maize). The Mikado purchase includes the European Economic Area (EEA) business and associated intellectual property rights, registrations and trademarks as well as production and formulation know-how. The business is to be sold in order to meet antitrust requirements. Syngenta AG was formed in November 2000 through the merger of Novartis Agribusiness and Zeneca Agrochemicals.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$105,871,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$105,870,639</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$105,871,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$105,870,639</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Syngenta AG /Mikado Brand Sulcotrione Herbicide Business/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Switzerland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures herbicides</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$29.671</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$29.181</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$30.308</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day LP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Syngenta AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Schwarzwaldallee 215, Basel, 4058 Switzerland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">41.61.323.11.11</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Michael Pragnell, Chief Executive</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SYNN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">H8414011</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Mayer Brown LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">May 19, 2016</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_2"></A><!-- Hide XML section from browser
<DOC NUMBER=3>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">3 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2016 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">proPlant Gesellschaft Fuer Agrar- Und Umweltinformatik mbH</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">proPlant Gesellschaft Fuer Agrar- Und Umweltinformatik mbH</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">February 19, 2016</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">February 15, 2016</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">February 15, 2016</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">859062</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">February 15, 2016</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired proPlant Gesellschaft Fuer Agrar- Und Umweltinformatik mbH for an undisclosed amount. The transaction enhances Bayer AG's portfolio of software solutions. Following the acquisition, proPlant Gesellschaft Fuer Agrar- Und Umweltinformatik mbH would be operating as Bayer Digital Farming GmbH. proPlant Gesellschaft Fuer Agrar- Und Umweltinformatik mbH is located in M&uuml;nster, Nordrhein-Westfalen, Germany and designs and develops innovative software solutions in agricultural sector.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">proPlant Gesellschaft Fuer Agrar- Und Umweltinformatik mbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Computer Software, Supplies &amp; Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Designs and develops innovative software solutions in agricultural sector</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$123.760</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$105.327</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$105.616</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">proPlant Gesellschaft Fuer Agrar- Und Umweltinformatik mbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Albrecht-Thaer-Stra&szlig;e 34, M&uuml;nster, 48147 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.251.98797.0</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7372 - Prepackaged software </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0139 - Field crops, except cash grains, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">February 24, 2016</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_3"></A><!-- Hide XML section from browser
<DOC NUMBER=4>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">4 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2016 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Steigerwald Arzneimittelwerk GmbH</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Steigerwald Arzneimittelwerk GmbH</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 20, 2016</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">May 16, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 1, 2013</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">755200</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 1, 2013</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Steigerwald Arzneimittelwerk GmbH for an undisclosed amount. The acquisition would expand Bayer AG's product offerings and would provide it with growth opportunities. Following the transaction, all employees of Steigerwald Arzneimittelwerk GmbH would join Bayer AG. The transaction was subject to certain closing conditions including antitrust clearance. The acquisition was expected to close at the beginning of July 2013. Steigerwald Arzneimittelwerk GmbH is located in Darmstadt, Hessen, Germany and manufactures plant extract-based medicine. It had sales of approximately EUR61.3 million (US$78.8 million) in 2012 and 180 employees.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Steigerwald Arzneimittelwerk GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures plant extract-based medicine</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2012</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">78.844</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2012</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">78.844</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$105.867</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$107.050</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$109.366</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Clifford Chance LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Steigerwald Arzneimittelwerk GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Havelstrasse 5, Darmstadt, 64295 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.6151.33050</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 25, 2016</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_4"></A><!-- Hide XML section from browser
<DOC NUMBER=5>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">5 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2016 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">CRISPR Therapeutics Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">CRISPR Therapeutics Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 4, 2016</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">December 21, 2015</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">852713</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture Minority Interest</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG agreed to acquire a undisclosed minority stake in CRISPR Therapeutics Ltd for CHF34.8 million (US$35 million) in cash. The transaction is subject to customary conditions, including merger control clearance in the United States. CRISPR Therapeutics Ltd is a portfolio company of SR One Ltd, New Enterprise Associates LLC, Versant Venture Management LLC and Abingworth Management Ltd. CRISPR Therapeutics Ltd is located in Basel, Basel-Stadt (Basle Town), Switzerland and develops gene-based medicines. The deal is expected to occur in the first quarter of 2016.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">-1.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$35,074,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$35,074,070</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$35,074,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$35,074,070</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CRISPR Therapeutics Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Switzerland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Health Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops gene-based medicines</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$131.276</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$119.788</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$125.899</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CRISPR Therapeutics Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Aeschenvorstadt 36, Basel, 4051 Switzerland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8093 - Specialty outpatient clinics, nec </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8049 - Offices of health practitioners, nec </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 9, 2016</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_5"></A><!-- Hide XML section from browser
<DOC NUMBER=6>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">6 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2015 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">SeedWorks International Pvt Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">SeedWorks International Pvt Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">June 3, 2015</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">June 1, 2015</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">828899</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG agreed to acquire SeedWorks International Pvt Ltd, also known as SeedWorks India Pvt Ltd, a portfolio company of Wand Partners Inc for an undisclosed amount. The acquisition will strengthen Bayer CropScience AG's vegetable seed business in India. Founded in 1998, SeedWorks International Pvt Ltd is located in Hyderabad, Andhra Pradesh, India and provides agricultural and farming services. It has around 180 employees and generated revenues of approximately INR1 billion (US$16.2 million) for the fiscal year 2013-2014. The deal is expected to close in the beginning of July 2015.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SeedWorks International Pvt Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">India</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricultural Production</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides agricultural and farming services</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">03/31/2014</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">16.206</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">03/31/2014</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">16.206</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$145</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$150.342</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$141.594</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SeedWorks International Pvt Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">437 Avenue 4, Banjara Hills, Hyderabad, 500 034 India</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">91.40.23356355</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0119 - Cash grains, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0112 - Rice</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 8, 2015</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_6"></A><!-- Hide XML section from browser
<DOC NUMBER=7>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">7 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2015 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Thermoplast Composite GmbH</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Thermoplast Composite GmbH</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 25, 2015</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 2, 2015</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 2, 2015</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">819181</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 2, 2015</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG, a subsidiary of Bayer AG, acquired Thermoplast Composite GmbH for an undisclosed amount. The acquisition would strengthen Bayer MaterialScience AG's position in key customer sectors and also allow entering into composites manufacturing industry. As part of the transaction, 12 employees of Thermoplast Composite GmbH would be retained by Bayer MaterialScience AG. Founded in 2007, Thermoplast Composite GmbH is located in Langenfeld, Nordrhein-Westfalen, Germany and produces thermoplastic fiber composites.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Thermoplast Composite GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Produces thermoplastic fiber composites</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$139.085</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$141.664</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$148.114</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Thermoplast Composite GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industriestrasse 1, Langenfeld, 91474 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.9164.99699.0</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2824 - Organic fibers, noncellulosic</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Lincoln International AG</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">March 30, 2015</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_7"></A><!-- Hide XML section from browser
<DOC NUMBER=8>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">8 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2015 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Cooperativa Central Ga&uacute;cha Ltda. /Seed Bus/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Cooperativa Central Ga&uacute;cha Ltda</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 20, 2015</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">January 19, 2015</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 19, 2015</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">814885</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 19, 2015</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG acquired the business and assets of the seed business of Cooperativa Central Ga&uacute;cha Ltda, for an undisclosed amount. Located in Cruz Alta, Brazil, the acquired business researches and develops agricultural seeds. The acquisition is subject to the regulatory approval from the Brazilian antitrust authority CADE (Conselho Administrativo de Defesa Econ&ocirc;mica). As of March 19, 2015, CADE had already approved the deal.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cooperativa Central Ga&uacute;cha Ltda. /Seed Bus/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Researches and develops agricultural seeds</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$146.582</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$137.961</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$141.984</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cooperativa Central Ga&uacute;cha Ltda</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Rodovia RS 342, Kilometro 149, Cruz Alta, 98005-970 Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0116 - Soybeans</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">March 25, 2015</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_8"></A><!-- Hide XML section from browser
<DOC NUMBER=9>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">9 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2014 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Kunming Dihon Pharmaceutical Co. Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Kunming Dihon Pharmaceutical Co. Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">December 17, 2014</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">February 27, 2014</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 3, 2014</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">780703</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 3, 2014</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Kunming Dihon Pharmaceutical Co Ltd, formerly known as Dihon Pharmaceutical Group Co Ltd, for RMB3.6 billion (US$587.8 million). The acquisition was subject to antitrust approval. Kunming Dihon Pharmaceutical Co Ltd is located in Yunnan, China and manufactures pharmaceutical products. With approximately 2,400 employees, the company generated RMB1 billion (US$168.1 million) in 2013 revenues. The transaction was expected to be completed in second half of 2014. On July 4, 2014, the Chinese Ministry of Commerce's anti-monopoly bureau has approved the transaction.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$587,429,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$587,429,131</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$587,429,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$587,429,131</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Kunming Dihon Pharmaceutical Co. Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">China</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides pharmaceutical products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2013</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">168.104</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2013</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">168.104</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$136.161</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$137.832</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$137.148</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Morgan Stanley</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Kunming Dihon Pharmaceutical Co. Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">45 Keyi Road, Kunming New &amp; High-Tech, Industrial Development Zone, Kunming, 650106 China</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">86.871.6832.2288</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2835 - In-Vitro and In-Vivo Diagnostice Manufacturing Substances</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">KPMG LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">December 22, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_9"></A><!-- Hide XML section from browser
<DOC NUMBER=10>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">10 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2014 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">E.I. Du Pont De Nemours &amp; Co. /Crop Protection Land Mgmt Ops/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">E.I. du Pont de Nemours &amp; Co.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">December 10, 2014</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 29, 2014</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">December 1, 2014</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">809738</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">December 1, 2014</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG acquired the business and assets of the Crop Protection Land Management business of EI Du Pont De Nemours &amp; Co for an undisclosed amount. The acquisition includes the Crop Protection Land Management assets of EI Du Pont De Nemours &amp; Co in the United States, Canada, Mexico, Australia and New Zealand. The acquisition would expand Bayer CropScience AG's pest and weed control business. Following the transaction, Barclift, product manager, would join Industrial Vegetation Management business and would lead the conceptualization, planning and implementation of marketing strategies and tactics for the Industrial Vegetation Management business and 16 employees from EI Du Pont De Nemours &amp; Co would join the Bayer Industrial Vegetation Management team in the United States. The transaction was subject to receipt of required antitrust approvals and was originally expected to close in the fourth quarter of 2014. The acquired business provides weed control solutions. The business has reported sales of US$63.7 million during the year 2013.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">E.I. Du Pont De Nemours &amp; Co. /Crop Protection Land Mgmt Ops/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">New York Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides weed control solutions</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$137.255</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$133.315</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$136.966</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">E.I. du Pont de Nemours &amp; Co.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1007 Market Street, Wilmington, DE 19898 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.302.774.1000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Gary M Pfeiffer, Senior VP/CFO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">DD</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">26353410</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">December 15, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_10"></A><!-- Hide XML section from browser
<DOC NUMBER=11>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">11 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2014 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Merck &amp; Co., Inc. /Consumer Healthcare Business/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Merck &amp; Co., Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">October 7, 2014</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">May 6, 2014</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">October 1, 2014</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">779339</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 1, 2014</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash, Bank Debt</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired the assets and operations of Merck &amp; Co Inc's consumer healthcare business for US$14.2 billion. Under the terms of the transaction, the agreement included an upfront payment of US$1 billion. The acquisition is in line with Merck &amp; Co Inc's strategy of keeping with its core businesses to maximize shareholder value. The acquisition also enhances the over-the-counter business of Bayer AG. The transaction was initially a rumor with a number of bidders interested to acquire the assets and operations of Merck &amp; Co Inc's consumer healthcare business for a value up to US$14 billion. Merck &amp; Co Inc hired Morgan Stanley to assist in the sales process. Sources reported that potential bidders included Novartis AG, Bayer AG, Reckitt Benckiser Group and Procter &amp; Gamble Co. The target business is located in the United States and manufactures consumer healthcare products. On February 12, 2014, Merck &amp; Co Inc reported that it received preliminary offers, with final bids due late in March. On March 25, 2014, it was reported that Sanofi SA was also interested in acquiring the target. On April 28, 2014, reports indicated that Merck &amp; Co Inc was in the final stages of selling its consumer healthcare business with Bayer AG and Reckitt Benckiser Group Plc being the final contenders in the auction process. Moreover, Reckitt Benckiser Group Plc confirmed that the company was in discussions with Merck &amp; Co Inc for a possible offer for its consumer healthcare business. On April 30, 2014, Reckitt Benckiser Group Plc confirmed that it was no longer in discussions for the consumer health business of Merck &amp; Co Inc. On May 1, 2014, reports surfaced that Bayer AG was in exclusive talks to acquire the consumer healthcare business of Merck &amp; Co. According to these reports, an announcement of the transaction was likely to happen in the next few days. Reports also cited that the consideration would include cash and exchange of assets. The transaction was originally expected to close by the second half of 2014. On June 18, 2014, Bayer AG obtained the US$14.2 billion syndicated loan comprised of US$12.2 billion bridge facility and a US$2 billion term loan, to fund the transaction.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,000,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,200,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,200,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,200,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Merck &amp; Co., Inc. /Consumer Healthcare Business/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">New York Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures consumer healthcare products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$132.763</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$136.991</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$138.785</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Merrill Lynch, Pierce, Fenner &amp; Smith, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Allen &amp; Overy LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sullivan &amp; Cromwell LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Merck &amp; Co., Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">One Merck Drive, Whitehouse Station, NJ 08889-3400 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.908.423.1000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Raymond Gilmartin, Chairman/President/CEO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MRK</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">58933Y10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2837 - </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">JP Morgan Chase Bank</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Morgan Stanley &amp; Co. LLC</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Morgan, Lewis &amp; Bockius LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Blake, Cassels &amp; Graydon LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">October 12, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_11"></A><!-- Hide XML section from browser
<DOC NUMBER=12>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">12 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2014 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Granar SA /Seed Business/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Granar SA</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">October 3, 2014</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 1, 2014</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">802673</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, agreed to acquire the business and assets of the seed business of Granar SA for an undisclosed amount. With this acquisition, Bayer CropScience AG enters the soybean seed market in Paraguay for the first time bringing a complete range of solutions to farmers. The business to be acquired is located in Paraguay and breeds, produces, and markets improved soybean seeds.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Granar SA /Seed Business/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paraguay</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricultural Production</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Breeds, produces, and markets improved soybean seeds</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$123.314</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$140.213</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$138.698</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Granar SA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paraguay</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0116 - Soybeans</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5153 - Grain and field beans </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">October 8, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_12"></A><!-- Hide XML section from browser
<DOC NUMBER=13>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">13 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2014 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Algeta ASA</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Algeta ASA</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 14, 2014</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 26, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 14, 2014</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">771659</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition Tender Offer</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Amendment Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">December 19, 2013</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 14, 2014</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Attitude:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Friendly</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Algeta ASA for an increased offer of about NOK15.9 billion (US$2.6 billion) in cash. Under the terms of the revised offer, Bayer AG paid NOK362 (US$59) per share, up from an initial offer NOK336 (US$54.8) per share. The acquisition allowed Bayer AG to strengthen its oncology portfolio. The deal was subject to certain conditions and including a minimum acceptance level of 90%. The Board of Directors of Algeta ASA unanimously recommended the increased offer to the company's shareholders. The deal was expected to be completed in the first quarter of 2014. According to sources dated November 25, 2013, Bayer AG was rumored to be interested to acquire Algeta ASA and was willing to pay NOK306 (US$50.36) for every share in the target company. As of the rumor date, the parties declined to confirm or deny the deal. On November 26, 2013, Algeta ASA confirmed the talks with Bayer AG; however, the company noted that the offer price per Algeta ASA share was NOK336 (US$54.8) instead of the earlier announced NOK306 (US$49.9) per Algeta ASA share. Discussions were at an early stage and there is no guarantee that it will lead to an agreement. As of December 19, 2013, Bayer AG has received pre-acceptances representing 14% of the issued share capital of Algeta ASA. Algeta ASA is located in Oslo, Norway and engages in the development of products for the treatment of cancer. On January 6, 2014, the German Federal Cartel Office cleared the transaction. The offer commenced on January 20, 2014 and was set to close on February 24, 2014. On February 24, 2014, the offer was extended until February 26, 2014. Bayer AG already holds 92.2% of the share capital of Algeta ASA. Upon expiration of the offer on February 26, 2014, Bayer AG announced that 42,731,347 shares, representing 97.3% of the issued share capital of Algeta ASA was already tendered. As of March 6, 2014, the bidder already holds 43,131,641 shares or a 98.2% stake in the target company. Furthermore, Bayer AG also announced that it intends to initiate a compulsorily acquisition process for the remaining shares of Algeta ASA not yet tendered. On March 14, 2014, Thomas Ramdahl was appointed as the Managing Director of Algeta ASA upon the completion of the transaction.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Premium Offered:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">.357</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$58.754788</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,191,058,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,669,629,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">37.179</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">15.375</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,580,803,208</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,580,803,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,580,803,208</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Algeta ASA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Norway</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Engages in the development of products for the treatment of cancer</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">09/30/2013</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">165.014</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">69.946</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">69.416</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">2.029</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.346</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">09/30/2013</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">165.014</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">69.946</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">69.416</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">2.029</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.346</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBITDA</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">35.685</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBIT</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">36.715</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$320,036,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$239,458,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Fully Diluted Common Stock</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">43,778,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$167,861,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3.832</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">43,803,996</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.585</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$36.449</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$43.313</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$43.248</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3.832</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$117.070</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$126.856</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$130.089</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Skandinaviska Enskilda Banken AB</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deutsche Bank Securities, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Simpson Thacher &amp; Bartlett LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Hannes Snellman Advokatbyr&aring; AB</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Algeta ASA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Kjels&aring;sveien 172 A, Oslo, 0884 Norway</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">23.00.79.90</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ALGETA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">R0207810</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">DNB ASA</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Centerview Partners LLC</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor | Fairness Opinion</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">The Goldman Sachs Group, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Skadden, Arps, Slate, Meagher &amp; Flom LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">July 19, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_13"></A><!-- Hide XML section from browser
<DOC NUMBER=14>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">14 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2014 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Radimetrics, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer HealthCare AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Radimetrics, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 10, 2014</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 26, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 26, 2012</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">739670</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 26, 2012</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer HealthCare AG, a subsidiary of Bayer AG, acquired Radimetrics Inc for an undisclosed amount. The transaction enhances Bayer HealthCare AG's portfolio of software solutions. As part of the transaction, all of the employees of Radimetrics Inc would join Bayer HealthCare AG. Founded in 2009, Radimetrics Inc is located in Toronto, Ontario, Canada and develops healthcare software.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Radimetrics, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Computer Software, Supplies &amp; Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops healthcare software</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer HealthCare AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$87.027</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$85.143</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$90.159</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Radimetrics, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">67 Mowat Avenue, Suite 544, Toronto, M6K 3E3 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.416.707.2399</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7372 - Prepackaged software </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">April 15, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_14"></A><!-- Hide XML section from browser
<DOC NUMBER=15>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">15 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2014 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Laboratorios BIAGRO SA</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Laboratorios BIAGRO SA</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 10, 2014</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 6, 2014</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">781485</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG agreed to acquire Laboratorios BIAGRO SA for an undisclosed amount. The transaction expands Bayer CropScience AG global SeedGrowth business. The acquisition is subject to the approval of antitrust authority in Argentina. Founded in 1984, Laboratorios BIAGRO SA is located in Gral Las Heras, Buenos Aires, Argentina and produces and distributes biological seed treatments. It has 140 employees.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Laboratorios BIAGRO SA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Argentina</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Produces and distributes biological seed treatments</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$128.391</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$136.800</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$137.486</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Laboratorios BIAGRO SA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Parque Industrial Gral, Casilla de correo, Gral Las Heras, Argentina</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">March 15, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_15"></A><!-- Hide XML section from browser
<DOC NUMBER=16>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">16 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2013 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">FN Semillas SA</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">FN Semillas SA</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">December 19, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">December 5, 2013</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">772733</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, agreed to acquire FN Semillas SA for an undisclosed amount. The acquisition would allow Bayer CropScience AG to enter into the soybean seed market in Argentina. The transaction would expand its customer base and market presence in Latin America. The deal will file for clearance before the Antitrust Authority in Argentina. Founded in 2010, FN Semillas SA is located in Salto, Buenos Aires, Argentina and produces and markets soybean seeds.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">FN Semillas SA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Argentina</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricultural Production</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Produces and markets soybean seeds</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$117.911</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$129.953</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$129.291</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Tanoira Cassagne Abogados</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">FN Semillas SA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ruta 31 Km 135,3, Salto, Argentina</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">54.024.7443.1363</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0116 - Soybeans</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Estudio Beccar Varela</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 21, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_16"></A><!-- Hide XML section from browser
<DOC NUMBER=17>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">17 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2013 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Schiff Nutrition International, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Healthcare LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Schiff Nutrition International, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">December 13, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 30, 2012</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">737169</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Public Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cancelled Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 21, 2012</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Attitude:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Friendly</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC, a subsidiary of Bayer AG, terminated its merger agreement to acquire Schiff Nutrition International Inc for US$996.1 million in cash. Under the deal terms, Bayer Healthcare LLC would have paid US$34 in cash per share, representing a 46% premium to Schiff Nutrition's closing stock price on October 26, 2012. The deal would have enabled further growth for Bayer Healthcare LLC. Schiff Nutrition International Inc is located in Salt Lake City, Utah, and manufactures nutritional supplements with around 400 employees. The deal would have closed by the end of 2012 and was subject to customary closing conditions. On November 15, 2012, Reckitt Benckiser Group Plc placed a bid to acquire Schiff Nutrition International Inc for approximately US$1.2 billion, offering US$42 cash for every target share. On November 20, 2012, Bayer Healthcare LLC announced that its offer still stands and that it will not raise its offer. On November 21, 2012, due to the superior offer of Reckitt Benckiser Group Plc, Schiff Nutrition International Inc terminated the agreement with Bayer Healthcare and paid US$22 million under the merger agreement.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BE = US$34 cash per share * 29,296,680 SHF os as of Sept 26, 2012</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Premium Offered:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">.446</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$34.000000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$996,087,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">66.172</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">-9.901</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$996,087,120</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,129,767,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$996,087,120</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Seller Breakup Fee:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$22,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Schiff Nutrition International, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">New York Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Retail</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures nutritional supplements</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">08/31/2012</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">285.806</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">25.014</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">15.053</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">7.097</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">5.134</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">08/31/2012</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">285.806</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">25.014</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">15.053</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">7.097</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">5.134</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBITDA</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">30.333</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBIT</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">37.474</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$337,146,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$17,291,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Long Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,400,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Long-Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$132,280,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Fully Diluted Common Stock</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">29,933,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$-100,605,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$-3.427</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">29,355,593</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$0.513</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$20.900</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$23.510</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$23.190</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$-3.427</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$84.991</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$85.394</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$85.818</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Merrill Lynch, Pierce, Fenner &amp; Smith, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day LP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sullivan &amp; Cromwell LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Schiff Nutrition International, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2002 South 5070 West, Salt Lake City, UT 84104-4726 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.801.975.5000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SHF</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">80669310</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5499 - Miscellaneous food stores </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">If the Merger Agreement is terminated, the Company may be required under circumstances specified in the Merger Agreement to pay to Parent a termination fee of $22.0 million</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Houlihan Lokey, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor | Fairness Opinion</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">$2,820,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Rothschild Holding AG</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">$4,240,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Latham &amp; Watkins LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 21, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_17"></A><!-- Hide XML section from browser
<DOC NUMBER=18>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">18 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2013 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Voith Paper Fabrics SA</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Eximium SAS</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Voith GmbH</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">November 29, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 30, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">October 30, 2013</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">771741</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 30, 2013</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Eximium SAS, a subsidiary of Baul&eacute; SAS and ultimately owned by Bayer AG, acquired Voith Paper Fabrics SA from Voith GmbH for an undisclosed amount. Founded in 1967, Voith Paper Fabrics SA is located in Guissona, Catalonia, Spain and manufactures press and dryer fabrics.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Voith Paper Fabrics SA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Spain</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Textiles</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures press and dryer fabrics</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Eximium SAS</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$117.356</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$125.619</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$127.106</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Voith GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sankt P&ouml;ltener Strasse 43, Heidenheim, 89522 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.7321.37.0</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Friedrich-Karl Finck, Chairman</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2231 - Broadwoven fabric mills, wool</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5199 - Nondurable goods, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">KPMG International</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 21, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_18"></A><!-- Hide XML section from browser
<DOC NUMBER=19>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">19 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2013 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Conceptus, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Healthcare LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Conceptus, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">June 21, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">April 29, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">June 5, 2013</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">753647</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition Tender Offer</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Public Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">June 5, 2013</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Attitude:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Friendly</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC, a subsidiary of Bayer AG, acquired Conceptus Inc for US$1 billion in cash. Under the terms of the deal, the bidder offered to pay US$31 cash per target share. The acquisition augments the bidder's birth control product offerings, particularly in the US market. Conceptus Inc is located in Mountain View, California, United States and develops and markets minimally invasive devices for reproductive medical applications. It employs 300 people. The deal was subject customary closing conditions, including anti-trust approvals. On May 7, 2013, Bayer Healthcare announced that the offer period started, which was stated to last until June 5, 2013. On May 29, 2013, it was announced that the US Federal Trade Commission has cleared the deal. On June 5, 2013, it was announced that at the close of the offer, 31,983,536 shares representing a 96.4% stake in the target have been validly tendered. On the same day, Bayer Healthcare exercised its top-up option, consummating the merger.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BE = US$31 cash * 32,542,457 CPTS o/s as of April 22, 2013</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Premium Offered:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">.222</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31.000000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,008,816,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,008,816,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.160</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7.066</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,008,816,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,008,816,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,008,816,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Seller Breakup Fee:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$37,300,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Conceptus, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">NASDAQ</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops and markets minimally invasive devices for reproductive medical applications</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2012</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">140.731</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">8.734</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">5.377</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">8.638</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">4.759</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">QUARTERLY RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10Q</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10Q</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">03/31/2013</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Prior Year</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">34.108</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">29.029</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">2.965</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-5.311</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1.857</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-2.838</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">2.043</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">2.181</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1.050</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1.440</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">03/31/2013</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">145.810</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">17.010</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">10.072</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">8.500</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">4.369</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBITDA</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">33.763</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBIT</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">47.187</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$258,032,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$21,867,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$142,767,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$4.480</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">31,867,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$0.316</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$23.260</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$25.370</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$25.900</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$4.480</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$102.221</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$101.468</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$105.727</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Merrill Lynch, Pierce, Fenner &amp; Smith, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sullivan &amp; Cromwell LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Shearman &amp; Sterling LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Conceptus, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">331 East Evelyn Avenue, Mountain View, CA 94041 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.650.962.4000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CPTS</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">20601610</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3841 - Surgical and medical instruments </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5047 - Medical and hospital equipment </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">in connection with the termination of the Merger Agreement in connection with a competing acquisition proposal and in other certain specified circumstances, the Company may be required to pay Parent a termination fee of $37.3 million.</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Goldman Sachs &amp; Co.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor | Fairness Opinion</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">$15,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 21, 2014</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_19"></A><!-- Hide XML section from browser
<DOC NUMBER=20>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">20 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2013 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Chiron Diagnostics Corp.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Chiron Corp.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 25, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">September 17, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 30, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">32970</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 30, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Chirons Diagnostic Unit for $1.1 billion in cash. The acquisition makes Bayer the fourth biggest company in the $19 billion global market for medical test kits. The Chiron unit has 3,000 employees in MA, OH, and CA, as well as the UK.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,100,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,100,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,100,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,100,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,100,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chiron Diagnostics Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">NASDAQ</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops medical diagnostic products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/17/1997</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">591.230</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/17/1997</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">591.230</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$43.151</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$37.825</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$38.716</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse Securities (USA) LLC (Broker)</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cravath, Swaine &amp; Moore LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sullivan &amp; Cromwell LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chiron Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">4560 Horton Street, Emeryville, CA 94608-2916 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.510.655.8730</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Martin Forrest, VP - Communications &amp; Investor Relations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CHIR</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">17004010</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2835 - In-Vitro and In-Vivo Diagnostice Manufacturing Substances</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse Securities (USA) LLC (Broker)</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sullivan &amp; Cromwell LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cleary Gottlieb Steen &amp; Hamilton LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">KPMG Peat Marwick LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">April 30, 2013</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_20"></A><!-- Hide XML section from browser
<DOC NUMBER=21>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">21 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2013 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Melhoramento Agropastoril Ltda. /Soy Germplasm Bank/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Melhoramento Agropastoril Ltda.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 16, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 6, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 6, 2013</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">749559</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 6, 2013</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, acquired the business and assets of soy germplasm bank, from Melhoramento Agropastoril Ltda for an undisclosed amount. The acquisition enhances Bayer CropScience AG's soybean business, and also expands its market presence in Latin America. In a separate but related transaction, Bayer CropScience AG also agreed to acquire Wehrtec and the soy business of Agricola Wehrmann Ltda. The acquired business manufactures and distributes pesticides, and vegetable seeds.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Melhoramento Agropastoril Ltda. /Soy Germplasm Bank/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and distributes pesticides, and vegetable seeds</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$100.313</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$97.202</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$101.594</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Melhoramento Agropastoril Ltda.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">April 21, 2013</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_21"></A><!-- Hide XML section from browser
<DOC NUMBER=22>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">22 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2013 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Wehrtec Tecnologia Agricola Ltda.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Agricola Wehrmann Ltda</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 11, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 6, 2013</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">749560</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, agreed to acquire Wehrtec Tecnologia Agricola Ltda, a subsidiary of Agricola Wehrmann Ltda for an undisclosed amount. The acquisition enhances Bayer CropScience AG's soybean business, and also expands its market presence in Latin America. Wehrtec Tecnologia Agricola Ltda is based in Brazil and engages in the breeding of soybeans, corn, sorghum, potatoes and garlic.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Wehrtec Tecnologia Agricola Ltda.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricultural Production</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Engages in the breeding of soybeans, corn, sorghum, potatoes and garlic</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$100.338</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$97.226</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$101.620</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricola Wehrmann Ltda</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Rod BR 251, km 49, Cristalina, 7005 Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">55.61.3504.0252</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0116 - Soybeans</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0119 - Cash grains, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">March 16, 2013</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_22"></A><!-- Hide XML section from browser
<DOC NUMBER=23>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">23 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2013 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">PROPHYTA Biologischer Pflanzenschutz GmbH</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">PROPHYTA Biologischer Pflanzenschutz GmbH</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">February 13, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">January 8, 2013</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">744105</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a unit of Bayer AG, agreed to acquire PROPHYTA Biologischer Pflanzenschutz GmbH for an undisclosed amount. The acquisition expands Bayer CropScience AG's product portfolio, strengthening its fruits and vegetables business activities. PROPHYTA Biologischer Pflanzenschutz GmbH, founded in 1992 and located in Malchow, Mecklenburg-Vorpommern, Germany, develops, produces and markets biological plant protection products and employs 30 people. The transaction is expected to be completed in the coming weeks.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PROPHYTA Biologischer Pflanzenschutz GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops, produces and markets biological plant protection products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$88.091</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$94.169</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$93.815</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day /Hong Kong/</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PROPHYTA Biologischer Pflanzenschutz GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Inselstrasse 12, Malchow, 23999 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.38425.230</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8731 - Commercial physical research </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">February 18, 2013</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_23"></A><!-- Hide XML section from browser
<DOC NUMBER=24>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">24 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2013 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">SDI Holding Corp</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Agfa Deutschland Vertriebsgesellschaft mbH &amp; Cie KG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">SDI Holding Corp</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 28, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">January 11, 1999</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">May 17, 1999</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">35639</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">May 17, 1999</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayers Agfa-Gevaert acquired SDI Holding Corp, the parent company of Sterling Diagnostic Imaging, for an undisclosed amount. Sterling Diagnostic reports annual worldwide sales of about $500 million.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SDI Holding Corp</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Over the Counter</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Wholesale &amp; Distribution</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Supplier of diagnostic medical X-ray film and equipment</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">04/11/1998</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">500.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">04/11/1998</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">500.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agfa Deutschland Vertriebsgesellschaft mbH &amp; Cie KG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$41.302</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$44.246</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42.168</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse Securities (USA) LLC (Broker)</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SDI Holding Corp</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Greenville, SC United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">78406710</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5047 - Medical and hospital equipment </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Citigroup Global Markets Inc. (Broker)</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Citigroup Global Markets, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cleary Gottlieb Steen &amp; Hamilton LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">February 2, 2013</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_24"></A><!-- Hide XML section from browser
<DOC NUMBER=25>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">25 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2013 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Teva Pharmaceutical Industries Ltd. /US Animal Health Bus/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Teva Pharmaceutical Industries Ltd. / Bayer AG / Bayer Healthcare LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Teva Pharmaceutical Industries Ltd. /US Animal Health Bus/</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 25, 2013</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">September 14, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 3, 2013</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">732852</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 3, 2013</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC, a subsidiary of Bayer AG, acquired the business and assets of the US animal health operations of Teva Pharmaceutical Industries Ltd for up to US$145 million in cash and contingent payout. As per the terms, Bayer Healthcare LLC would pay US$60 million in upfront payment and US$85 million, subject to certain manufacturing and sales milestones. The acquisition enables the bidder to expand its animal health operations in the United States. The target business unit manufactures and supplies animal food products, and employs approximately 300 people. The deal, pending antitrust clearance and other closing conditions, was expected to close in 2013.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$145,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$145,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$60,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$145,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contingent Payment Amount:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$85,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$145,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Teva Pharmaceutical Industries Ltd. /US Animal Health Bus/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Food Processing</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and supplies animal food products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Teva Pharmaceutical Industries Ltd. / Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$73.687</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$82.797</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$84.742</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day LP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Teva Pharmaceutical Industries Ltd. /US Animal Health Bus/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2048 - Prepared feeds, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5999 - Miscellaneous retail stores, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 30, 2013</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_25"></A><!-- Hide XML section from browser
<DOC NUMBER=26>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">26 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2012 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Abbott &amp; Cobb, Inc. /Watermelon &amp; Melon Seed Business/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Abbott &amp; Cobb, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">November 21, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">June 12, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 2, 2012</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">723747</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 2, 2012</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, acquired the watermelon and melon seed business of Abbott &amp; Cobb Inc for US$ 53 million. The transaction will enable Bayer CropScience AG to increase its own seed portfolio and to profit from the forecasted growth of the vegetable seed market. Around 30 of the acquired business' employees would be absorbed by Bayer. The business for acquisition is based in Pennsylvania, United States, and produces watermelon and melon seeds. On June 16, 2012, it was announced that the deal was expected to be completed within a few weeks.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$53,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$53,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$53,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Abbott &amp; Cobb, Inc. /Watermelon &amp; Melon Seed Business/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricultural Production</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Produces watermelon and melon seeds</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$70.426</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$59.784</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$62.630</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Abbott &amp; Cobb, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Feasterville Trevose, PA 19053 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.520.281.1612</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0179 - Fruit and tree nuts, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">November 26, 2012</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_26"></A><!-- Hide XML section from browser
<DOC NUMBER=27>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">27 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2012 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">KMG Chemicals, Inc. /Animal Health Bus/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Healthcare LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">KMG Chemicals, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">October 16, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">February 16, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 1, 2012</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">711990</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 1, 2012</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC, a subsidiary of Bayer AG, acquired business and assets of KMG Chemicals Inc's animal health business for US$10.2 million. The acquisition, expected to close before 31 March 2012, is part of Bayer Healthcare's strategy to strengthen its animal health portfolio. Also, the consideration includes US$1 million in escrow. The acquired business manufactures and distributes specialty chemicals for animal healthcare, and has reported sales of US$11.4 million in 2011.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">KMG Chemicals, Inc. /Animal Health Bus/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">New York Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and distributes specialty chemicals for animal healthcare</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$66.869</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$73.491</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$72.595</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">KMG Chemicals, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">9555 West Sam Houston Parkway South, Suite 600, Houston, TX 77099 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.713.600.3800</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">John V Sobchak, CFO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">KMG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">48256410</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">October 21, 2012</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_27"></A><!-- Hide XML section from browser
<DOC NUMBER=28>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">28 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2012 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">AgraQuest, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">AgraQuest, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">August 16, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">July 3, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">August 16, 2012</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">725940</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">August 16, 2012</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, acquired AgraQuest Inc for US$425 million. The transaction enhances Bayer CropScience AG's its fruits and vegetables business. The transaction was subject to customary closing conditions and approval by authorities. AgraQuest Inc has around 250 employees. AgraQuest Inc is based in Davis, California, and develops pesticides and provides best management services.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$425,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$425,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$425,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$425,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">AgraQuest, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Over the Counter</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops pesticides and provides best management services</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$66.418</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$66.483</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$72.333</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day LP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">AgraQuest, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1540 Drew Avenue, Davis, CA 95618 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.530.750.0150</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">00849E10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">August 21, 2012</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_28"></A><!-- Hide XML section from browser
<DOC NUMBER=29>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">29 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2012 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Baul&eacute; SAS</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Eximium SAS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 20, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 30, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 30, 2012</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">716387</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 30, 2012</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG, a subsidiary of Bayer AG, acquired the remaining 50% stake not already owned in Baul&eacute; SAS, from its joint venture partner Eximium SAS for an undisclosed amount. The acquisition enhances Bayer MaterialScience AG's product portfolio and also expands its market presence. Following the acquisition, Dr. Wilhelm Lamberts, current Bayer MaterialScience Oldenburg GmbH &amp; Co KG managing director, became president of Baul&eacute; SAS. Baul&eacute; SAS's employees would join with Bayer MaterialScience AG. Founded in 2008, Baul&eacute; SAS is based in Romans, Centre, France, and manufactures and supplies polyurethanes products. It has 139 employees.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Owned Before:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">50.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">50.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Baul&eacute; SAS</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">France</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and supplies polyurethanes products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$74.802</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$71.166</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$69.568</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">KPMG LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Eximium SAS</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">46, avenue des Allobroges, Romans, 26103 France</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">33.4.75.72.72.75</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Joint Venture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2821 - Plastics materials and resins</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">July 25, 2012</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_29"></A><!-- Hide XML section from browser
<DOC NUMBER=30>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">30 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2012 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Arkema, Inc. /Polycarbonate Sheet Business/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Arkema SA</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 12, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">April 12, 2012</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">717483</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience LLC subsidiary of Bayer AG agreed to acquire the business and assets of Polycarbonate Sheet Business from Arkema SA for an undisclosed amount. The transaction expands the company's product portfolio. The acquisition also includes products Tuffak, used in aerospace equipments. Polycarbonate Sheet Business is based in United States and manufactures vinyl products.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Arkema, Inc. /Polycarbonate Sheet Business/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures vinyl products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Kaiser-Wilhelm-Allee 1, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$74.957</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$71.937</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$67.164</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Arkema SA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">420, rue d'Estienne d'Orves, Colombes, 92700 France</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">33.1.49.00.80.80</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">AKE</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">F0392W12</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3999 - Manufacturing industries, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">April 17, 2012</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_30"></A><!-- Hide XML section from browser
<DOC NUMBER=31>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">31 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2012 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">BayOne Urethane Systems LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">PolyOne Corp.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">February 20, 2012</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 30, 2011</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 30, 2011</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">567491</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 30, 2011</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience LLC, a unit of Bayer AG, acquired the remaining 50% stake in BayOne Urethane Systems LLC from PolyOne Corp for US$19.3 million in cash. The transaction stems from the plans of PolyOne Corp to reposition its current business portfolio. BayOne Urethane Systems LLC is a joint-venture company between PolyOne Corp and Bayer AG. Based in St Louis, United states, BayOne Urethane Systems LLC develops, manufactures and distributes polymers.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Owned Before:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">50.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">50.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$19,300,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$19,300,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$19,300,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$19,300,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BayOne Urethane Systems LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">New York Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops, manufactures and distributes polymers</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Kaiser-Wilhelm-Allee 1, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$60.846</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$57.952</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$61.061</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PolyOne Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">33587 Walker Road, Avon Lake, OH 44012 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.440.930.1000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Joint Venture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">POL</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">73179P10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2821 - Plastics materials and resins</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5162 - Plastics materials &amp; basic shapes </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">March 1, 2012</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_31"></A><!-- Hide XML section from browser
<DOC NUMBER=32>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">32 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2011 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Schering AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Schering AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">December 29, 2011</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 23, 2006</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">June 20, 2006</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">368855</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition Tender Offer</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">June 20, 2006</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Attitude:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Friendly</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">German pharmaceuticals giant Bayer AG acquired a 78.2% majority stake Schering AG for EUR86 (US$102.5) per share in cash. Thus, the total consideration for the transaction amounts to about EUR13.1 billion (US$16.8 billion). Schering AG is a Germany based manufacturer of pharmaceuticals and diagnostic substances. The company, which had just received a hostile takeover bid from German pharmaceutical manufacturer Merck KGaA on March 13, 2006, welcomed Bayer's proposal and has stated its intention to approve the offer and recommend acceptance by the company's stockholders, according to a statement by the business. Bayer AG's Management Board Chairman Werner Wenning said that the takeover of Schering AG is in line with Bayer's strategic objective to further grow its health care business, especially in the area of pharmaceutical specialty products. On May 25, 2006, the Competition Commission approved the transaction. On June 14, 2006, Bayer AG agreed to acquire the remaining 21.8% stake in Schering AG from Merck KGaA at an increased offer price of EUR89 (US$114.3) per share. The deal allows Bayer AG to go through with its original offer.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BE = 194,200,000 Schering AG s/o * 78.2% * EUR86 = 13,060,338,400. related deal #367463.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Premium Offered:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">.416</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">78.200%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$103.059200</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$15,651,024,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$16,421,168,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">26.765</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">6.451</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$15,651,023,693</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$16,030,558,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$15,651,023,693</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Schering AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Over the Counter</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures pharmaceuticals and diagnostic substances</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2005</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6,360.910</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1,162.412</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">747.778</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">417.030</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">17.975</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2005</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6,360.910</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1,162.412</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">747.778</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">417.030</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">17.975</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBITDA</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">12.833</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBIT</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">17.367</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$7,313,608,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$929,930,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Long Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$32,356,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other Short-Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$141,407,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Long-Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$273,227,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other Long Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$38,348,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3,102,561,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$15.976</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">194,200,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3.851</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$67.060</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$72.777</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$80.123</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Kaiser-Wilhelm-Allee 1, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$15.976</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$41.068</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$39.534</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40.445</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse (United States)</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Greenhill &amp; Co., Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Citigroup, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day LP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Latham &amp; Watkins LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Schering AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">M&uuml;llerstrasse 170/178, Berlin, 13353 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.30.4681111</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Hubertus Erlen, Chairman</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0845K10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2835 - In-Vitro and In-Vivo Diagnostice Manufacturing Substances</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Dresdner Kleinwort Wasserstein</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cravath, Swaine &amp; Moore LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 3, 2012</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_32"></A><!-- Hide XML section from browser
<DOC NUMBER=33>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">33 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2011 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Raps GbR /Oilseed Rape Business/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">P. H. Petersen Saatzucht Lundsgaard GmbH &amp; Co. KG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">October 7, 2011</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 7, 2011</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">October 7, 2011</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">602508</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 7, 2011</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, acquired the business and assets of the Oilseed Rape business of Raps GbR, a subsidiary of P. H. Petersen Saatzucht Lundsgaard GmbH &amp; Co KG for an undisclosed amount. The acquisition includes all available breeding materials and products of Raps GbR that are in the market. The acquisition would strengthen the oilseed rape breeding business of Bayer CropScience AG and further expand its business in the European oilseed rape market. The acquired Oilseed Rape business of Raps GbR breeds and supplies spring and winter oilseed rape.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Raps GbR /Oilseed Rape Business/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricultural Production</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Breeds and supplies spring and winter oilseed rape</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$58.454</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$55.924</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$55.506</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">P. H. Petersen Saatzucht Lundsgaard GmbH &amp; Co. KG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Streichm&uuml;hler Strasse 8 a, Grundhof, 24977 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.4636.89.0</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0119 - Cash grains, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5159 - Farm-product raw materials, nec </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">October 12, 2011</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_33"></A><!-- Hide XML section from browser
<DOC NUMBER=34>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">34 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2011 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Pathway Medical Technologies, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / MEDRAD, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Pathway Medical Technologies, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">September 30, 2011</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">September 1, 2011</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">September 1, 2011</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">598326</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">September 1, 2011</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MEDRAD Inc, a subsidiary of Bayer HealthCare AG, itself ultimately owned by Bayer AG, acquired Pathway Medical Technologies Inc for an undisclosed amount. The transaction would strengthen the position of MEDRAD Inc in the field of vascular intervention technologies. Based in Kirkland, Washington, Pathway Medical Technologies Inc manufactures, develops and markets medical devices for treatment of arterial disease.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pathway Medical Technologies, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures, develops and markets medical devices for treatment of arterial disease</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MEDRAD, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$81.489</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$62.969</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$64.633</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day LP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pathway Medical Technologies, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">10801 120th Avenue Northeast, Kirkland, WA 98033 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.425.636.4000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3841 - Surgical and medical instruments </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">October 5, 2011</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_34"></A><!-- Hide XML section from browser
<DOC NUMBER=35>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">35 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2011 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Hornbeck Seed Co., Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Hornbeck Seed Co., Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 28, 2011</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 23, 2011</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 28, 2011</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">580041</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 28, 2011</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, acquired Hornbeck Seed Co Inc for US$42.6 million. The acquisition provides an opportunity for Bayer CropScience AG to expand its soybean seed market business in Southern US. Based in Arkansas, Hornbeck Seed Co Inc supplies soybean, rice and wheat variety seeds.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42,635,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42,635,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42,635,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42,634,500</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Hornbeck Seed Co., Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Wholesale &amp; Distribution</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Supplies soybean, rice and wheat variety seeds</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.301</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$75.800</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$71.234</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$75.491</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Hornbeck Seed Co., Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">210 Drier Road, DeWitt, AR 72042 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.888.425.7333</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5153 - Grain and field beans </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">August 2, 2011</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_35"></A><!-- Hide XML section from browser
<DOC NUMBER=36>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">36 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2011 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Bomac Laboratories Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Bomac Laboratories Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">May 18, 2011</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 3, 2010</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 7, 2011</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">564223</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 7, 2011</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Bomac Laboratories Ltd for NZ $124.2 million (US$93.9 million). The acquisition will strengthen Bayer AG's animal health business in Asia Pacific and Latin America. The transaction was subject to regulatory approvals and was expected to be completed in early 2011. Based in New Zealand and founded in 1958, Bomac Laboratories Ltd manufactures animal health products.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$96,254,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$94,627,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$96,254,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$96,253,500</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bomac Laboratories Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures animal health products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.301</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$71.527</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$78.885</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$76.811</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bomac Laboratories Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cnr Wiri Station Road &amp; Hobill Ave, Auckland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">64.9.262.3169</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2048 - Prepared feeds, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Macquarie Capital Advisers Ltd.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">May 23, 2011</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_36"></A><!-- Hide XML section from browser
<DOC NUMBER=37>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">37 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2011 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Topsun Technology &amp; Science Qidong /OTC Cough &amp; Cold/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer HealthCare /Consumer Care Division/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Topsun Technology &amp; Science Co. Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 28, 2011</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 25, 2006</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 1, 2010</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">395814</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 1, 2010</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer HealthCare Consumer Care Division, which belongs to Bayer HealthCare AG, acquired the entire business and assets of the Western Over-the-Counter Cough &amp; Cold Portfolio from Topsun Technology &amp; Science Qidong Gaitianli Pharmaceutical Co Ltd, a subsidiary of Shanghai-listed Topsun Technology &amp; Science Co Ltd, for approximately RMB1.1 billion (US$135.7 million). Based in Qidong, Jiangsu Province, the target includes a manufacturing facility located in Qidong, a national sales force and distribution network associated with the brands. The Cough &amp; Cold Portfolio generated approximately RMB331 million (US$41 million) in sales of the year 2005. Considering China is one of the fastest growing markets of OTC medicines in the world, the acquisition would strengthen the bidder's presence there.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$135,689,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$158,120,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$135,688,898</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$135,689,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$135,688,898</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Topsun Technology &amp; Science Qidong /OTC Cough &amp; Cold/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">China</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and distributes over-the-counter cough and cold medicines in Western China</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer HealthCare /Consumer Care Division/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.301</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$49.479</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$50.291</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$51.193</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Topsun Technology &amp; Science Co. Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Topsun Building, No. 23 Tangyan Road, Xi'an High-Tech Zone, Xi'an, 710075 China</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">86.29.88332288</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">600771</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Y7170Z10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5122 - Drugs, proprietaries, and sundries </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Clifford Chance US LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">February 2, 2011</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_37"></A><!-- Hide XML section from browser
<DOC NUMBER=38>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">38 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2010 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">DIREVO Biotech AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer HealthCare AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">DIREVO Biotech AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">September 9, 2010</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">September 16, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">September 16, 2008</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">490895</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">September 16, 2008</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer HealthCare AG, a subsidiary of Bayer AG, acquired DIREVO Biotech AG for EUR210 million (US$298 million) in cash. DIREVO Biotech AG is a German research company that specializes in the research of proteins and bio-molecules as well as bioengineered products and processes for the industrial and pharmaceutical markets. The acquisition of DIREVO Biotech AG does not include the company's wholly owned subsidiary DIREVO Industrial Biotechnology GmbH, which has been sold in a separate deal to a group of financial investors.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$296,551,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$296,551,495</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$296,551,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$296,551,495</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">DIREVO Biotech AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Researches on screening-based directed evolution of genes and proteins</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer HealthCare AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.301</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$78.346</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$75.324</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$78.996</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Linklaters LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">DIREVO Biotech AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Nattermannallee 1, Cologne, 50829 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.221.8887.0</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8731 - Commercial physical research </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Mummert &amp; Co. Corporate Finance GmbH</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Mayer Brown LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">September 14, 2010</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_38"></A><!-- Hide XML section from browser
<DOC NUMBER=39>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">39 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2010 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Possis Medical, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / MEDRAD, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Possis Medical, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">May 7, 2010</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">February 11, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 3, 2008</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">459007</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition Tender Offer</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Public Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 3, 2008</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Attitude:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Friendly</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MEDRAD Inc, part of Bayer HealthCare AG, which is a subsidiary of Bayer AG, acquired Possis Medical Inc, via a cash tender offer for approximately US$332.2 million. Under the terms of the agreement, each share of Possis Medical Inc was tendered for US$19.50. This represents about a 36% premium over Possis Medical Inc's February 8, 2007 close price of US$14.35. Possis Medical Inc is a medical device manufacturer that develops a product which removes intra-vascular blood clots. With the acquisition, MEDRAD Inc continues its commitment to the treatment of patients in the growing cardiovascular intervention field.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BE = cash (17,034,157 POSS shares outstanding as of 8-Feb-08 * US$19.50)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Premium Offered:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">.414</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$19.500000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$332,166,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$332,166,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">420.463</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">4.329</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$332,166,062</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$332,166,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$332,166,062</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Seller Breakup Fee:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$11,100,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Possis Medical, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">NASDAQ</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops, manufactures, and markets medical products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">07/31/2007</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">66.655</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.909</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.056</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">2.889</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">QUARTERLY RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10Q</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10Q</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">01/31/2008</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Prior Year</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">39.502</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">31.410</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1.207</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-0.119</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.674</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-0.060</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1.667</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1.411</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">01/31/2008</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">74.747</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">2.235</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.790</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.145</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBITDA</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">61.741</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBIT</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">148.620</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$86,875,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$5,078,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$76,725,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$4.504</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">17,033,157</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$0.046</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14.470</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13.790</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14.350</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MEDRAD, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.301</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$4.504</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$91.950</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$82.920</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$79.210</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Morgan Stanley</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cohen &amp; Grigsby</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Possis Medical, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">9055 Evergreen Boulevard Northwest, Minneapolis, MN 55433-8003 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.763.780.4555</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">POSS</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">73740710</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3841 - Surgical and medical instruments </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5047 - Medical and hospital equipment </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Greene Holcomb &amp; Fisher LLC</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor | Fairness Opinion</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">$2,380,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Dorsey &amp; Whitney LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">May 11, 2010</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_39"></A><!-- Hide XML section from browser
<DOC NUMBER=40>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">40 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2010 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Artificial Muscle, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Artificial Muscle, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 9, 2010</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 9, 2010</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 9, 2010</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">538629</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 9, 2010</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience LLC, a subsidiary of Bayer MaterialScience AG and ultimately owned by Bayer AG, acquired Artificial Muscle Inc for an undisclosed amount. Pursuant to the acquisition, all employees of Artificial Muscle Inc, including Scott Metcalf, its President and Chief Executive Officer, will be retained. The acquisition provides an opportunity for Bayer MaterialScience LLC to expand into a new market sector. It also strengthens Bayer MaterialScience LLC's position as a solution provider. Based in Sunnyvale, California, Artificial Muscle Inc designs and manufactures actuator and sensing components.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Artificial Muscle, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Internet; Electronics</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Designs and manufactures actuator and sensing components</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2007</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.750</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2007</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.750</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.301</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$71.749</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$69.319</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$70.775</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Artificial Muscle, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">749 North Mary Avenue, Sunnyvale, CA 94085 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.408.215.7320</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3679 - Electronic components, nec </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3593 - Fluid power cylinders &amp; actuators </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">March 12, 2010</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_40"></A><!-- Hide XML section from browser
<DOC NUMBER=41>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">41 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2010 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Athenix Corp.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Athenix Corp.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 15, 2010</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">August 19, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 2, 2009</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">521208</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 2, 2009</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, acquired Athenix Corp for US$400 million. Under the acquisition terms, Bayer CropScience AG paid US$400 million which includes up to US$35 million upon achievement of certain development milestones. As a result of the transaction, Bayer CropScience AG was able to boost its technological platform. Athenix Corp is a biotechnology company engaging in herbicide tolerance and insect control platforms for corn and soybeans.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$400,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$400,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$400,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contingent Payment Amount:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$35,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$400,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Athenix Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops agricultural herbicide tolerance and insect control chemicals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2007</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.700</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2007</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.700</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.301</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides health care, nutrition and high-tech material services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$50.340</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$61.426</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$60.194</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Athenix Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Research Triangle Park, 108 T.W. Alexander Drive, Durham, NC 27709 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.919.328.4100</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 21, 2010</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_41"></A><!-- Hide XML section from browser
<DOC NUMBER=42>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">42 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2009 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">PolyBioMed Ltd</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Lombard Medical PLC</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">November 30, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 17, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 30, 2009</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">527902</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 30, 2009</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG, a subsidiary of Bayer AG, acquired PolyBioMed Ltd, a wholly-owned subsidiary of Lombard Medical Plc, for GBP1 million (US$1.7 million) in cash. The acquisition will help Bayer MaterialScience AG expand its product portfolio for medical technology and will give them access to application areas such as coronary drug-eluting stents plus catheter systems for interventional cardiology, urology and neurology. PolyBioMed Ltd was founded in 1996 and is based in Sheffield, United Kingdom. It develops polymer chemistry to modify surface properties of devices for medical and non-medical applications.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,680,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,641,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,679,550</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,680,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,679,550</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PolyBioMed Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United Kingdom</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">London Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops polymer chemistry to modify surface properties of devices for medical and non-medical applications</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAYN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0712D16</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$73.782</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$74.621</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$78.193</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Lombard Medical PLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Lombard Medical House, 4 Trident Park, Didcot, OX11 7HJ United Kingdom</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">44.1235.750800</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">G5559L10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8731 - Commercial physical research </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3841 - Surgical and medical instruments </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">December 4, 2009</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_42"></A><!-- Hide XML section from browser
<DOC NUMBER=43>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">43 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2009 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Bayer Polymers (Shanghai) Co. Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Shanghai Chlor-Alkali Chemical Co. Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 16, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">April 15, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 15, 2009</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">510337</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 15, 2009</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG won an auction and acquired the remaining 10% of Bayer Polymers (Shanghai) Co Ltd from Shanghai Chlor-Alkali Chemical Co Ltd for RMB230 million (US$33.7 million) in cash. Based in Shanghai, the target is primarily engaged in the manufacture of polycarbonate, polymers and other related plastic products.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Owned Before:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">90.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">10.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$33,664,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$33,664,118</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$33,664,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$33,664,118</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Polymers (Shanghai) Co. Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">China</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures polymers</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$46.295</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$49.541</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$49.512</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Shanghai Chlor-Alkali Chemical Co. Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">No. 4747 Longwu Road, Shanghai, 200241 China</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">86.21.64342640</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">600618</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Y7677113</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2821 - Plastics materials and resins</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">April 21, 2009</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_43"></A><!-- Hide XML section from browser
<DOC NUMBER=44>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">44 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2009 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Monochem SA</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">The Carlyle Group LLC</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 15, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">April 1, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 1, 2009</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">510285</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 1, 2009</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG, a subsidiary of Bayer AG, acquired Monochem SA, a subsidiary of Neochimiki SA and ultimately owned by The Carlyle Group LLC, for an undisclosed amount. Monochem SA produces polyurethane insulating materials, industrial floorings and chemical auxiliary materials for the tanning and textile industry. The acquisition expands Bayer MaterialScience AG's systems house business in southeast Europe.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Monochem SA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Greece</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Plastics &amp; Rubber</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Produces polyurethane insulating materials, industrial floorings and chemical auxiliary materials for the tanning and textile industry</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$56.234</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$50.996</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$47.623</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">The Carlyle Group LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1001 Pennsylvania Avenue NW, Washington, DC 20004-2505 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.202.729.5626</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sterling Philps, Vice President</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3086 - Plastics foam products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3441 - Fabricated structural metal </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">April 20, 2009</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_44"></A><!-- Hide XML section from browser
<DOC NUMBER=45>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">45 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2009 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Agrogreen Ltd. /Crop Protection Ops/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Minrav Holdings Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 3, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 31, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 31, 2009</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">509373</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 31, 2009</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience SA acquired the assets and business of the crop protection operation from Agrogreen Ltd for an undisclosed amount. The acquired asset is the manufacturing and distribution operation of biological pesticides including Agrogreen's major product line called BioNem.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agrogreen Ltd. /Crop Protection Ops/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Israel</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and distributes pesticides</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share prices partially unavailable</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$50.334</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$47.644</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Minrav Holdings Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3 Habosem Street, Kiryat Minrav, Ashdod, 77610 Israel</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">972.8.851.6262</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MNRV</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">M7027110</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5191 - Farm supplies </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">April 8, 2009</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_45"></A><!-- Hide XML section from browser
<DOC NUMBER=46>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">46 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2009 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Bayer Sanmar Ltd</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Sanmar Holdings Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">February 25, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">August 9, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">August 9, 2001</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">169904</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">August 9, 2001</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired the remianing 49% stake it did not already own in its joint venture Bayer Sanmar Ltd from Sanmar Group for an undisclosed amount. The joint venture was formed in 1996 and manufactures thermoplastic polyurethanes.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Owned Before:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">51.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Sanmar Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">India</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures polyurethanes and thermoplastic urethanes</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sanmar Holdings Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">9 Cathedral Road, Chennai, 600 086 India</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">91.44.28128500</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">March 2, 2009</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_46"></A><!-- Hide XML section from browser
<DOC NUMBER=47>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">47 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2009 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">BaySystems B&Uuml;FA Polyurethane GmbH &amp; Co. KG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">B&uuml;sing &amp; Fasch GmbH &amp; Co. KG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 20, 2009</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">April 21, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 21, 2008</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">471873</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 21, 2008</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG, a subsidiary of Bayer AG, acquired the remaining 50% in BaySystems B&Uuml;FA Polyurethane GmbH &amp; Co KG from B&uuml;sing &amp; Fasch GmbH &amp; Co KG for an undisclosed sum. BaySystems B&Uuml;FA Polyurethane GmbH &amp; Co KG specializes in the manufacture of foams and elastomers. B&Uuml;FA Polyurethane GmbH &amp; Co KG, originally a subsidiary of B&uuml;sing &amp; Fasch GmbH &amp; Co KG, was in 2003 re-organized into a joint-venture business between Bayer MaterialScience AG and B&uuml;sing &amp; Fasch GmbH &amp; Co KG. In the beginning of 2006, B&Uuml;FA Polyurethane GmbH &amp; Co KG changed its name to BaySystems B&Uuml;FA Polyurethane GmbH &amp; Co KG.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Owned Before:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">50.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">50.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BaySystems B&Uuml;FA Polyurethane GmbH &amp; Co. KG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures integral foams, elastomers and rigid foam</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$75.613</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$81.455</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$83.890</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">B&uuml;sing &amp; Fasch GmbH &amp; Co. KG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Mittelkamp 112, Oldenburg, 26125 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.441.9317.0</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Joint Venture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 23, 2009</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_47"></A><!-- Hide XML section from browser
<DOC NUMBER=48>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">48 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2008 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Sagmel, Inc. (Over the Counter Business)</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Healthcare LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Sagmel, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">October 14, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 12, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">June 3, 2008</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">464563</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Conglomerate</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">June 3, 2008</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC, which is a subsidiary of Bayer AG, acquired the business and assets of Sagmel Inc's over-the counter business for an undisclosed amount. Bayer Healthcare LLC provides healthcare and laboratory testing services while Sagmel Inc's over-the counter business manufactures pharmaceuticals in Russia, Belarus, Kazakhstan, and Ukraine.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sagmel, Inc. (Over the Counter Business)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Russia</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures pharmaceuticals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$80.689</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$74.549</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$72.456</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Clifford Chance LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sagmel, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1580 South Milwaukee Avenue, Suite 4, Libertyville, 60048 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.847.573.0802</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Mayer Brown LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">October 17, 2008</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_48"></A><!-- Hide XML section from browser
<DOC NUMBER=49>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">49 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2008 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Boots Healthcare International Ltd</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Boots Group PLC</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 30, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">September 30, 2005</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">351060</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cancelled Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 7, 2005</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG lost its bid for Boots Healthcare International Ltd, a subsidiary of Boots Group Plc for an undisclosed amount. Other companies interested in the company include GlaxoSmithKline, Reckitt Benckiser, Johnson and Johnson, Procter and Gamble and Novartis.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Boots Healthcare International Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United Kingdom</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">London Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures healthcare and beauty goods</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">03/31/2005</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">987.694</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">165.907</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">03/31/2005</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">987.694</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">165.907</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$34.694</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$35.118</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$36.484</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Boots Group PLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1 Thane Road West, Nottingham, NG2 3AA United Kingdom</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">44.115.9506111</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BOOT</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">G0246510</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">May 13, 2008</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_49"></A><!-- Hide XML section from browser
<DOC NUMBER=50>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">50 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2008 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Elastochem Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Rhein Chemie Corp.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Elastochem Inc</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 30, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">September 21, 1999</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">October 31, 1999</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">42688</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 31, 1999</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, through its Rhein Chemie Corp subsidiary, acquired the assets of Elastochem for USD64.4 million. The deal is expected to complement Rhein Chemies current product line and expand its existing customer base.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$64,434,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$64,434,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$64,434,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$64,434,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Elastochem Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures additives and specialty products for the rubber, plastics, and polyurethane and lubricant oil industries</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Rhein Chemie Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,860,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$845,770,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$21.560</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$21.740</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$21.090</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Elastochem Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">145 Parker Court, Chardon, OH 44024-1112 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2821 - Plastics materials and resins</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2992 - Lubricating oils and greases</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">May 13, 2008</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_50"></A><!-- Hide XML section from browser
<DOC NUMBER=51>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">51 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2008 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">PFWs Worldwide Fragrances Business</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Haarman &amp; Reimer Corp</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Hercules, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 30, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">January 29, 1992</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 29, 1992</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">7461</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Vertical</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 29, 1992</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Haarman &amp; Reimer Corp, a subsidiary of Bayer AG, acquired the worldwide fragrances business of PFW, a division of Hercules Inc, for an undisclosed amount.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PFWs Worldwide Fragrances Business</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">New York Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Toiletries &amp; Cosmetics</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Produces &amp; distributes fragrances</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">04/29/1991</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">35.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">04/29/1991</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">35.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Haarman &amp; Reimer Corp</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Subsidiary phone: 201-451-5600.</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Hercules, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Hercules Plaza, 1313 North Market Street, Wilmington, DE 19894 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.302.594.5000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sue Towers, VP/Treasurer</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">HPC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">42705610</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">May 13, 2008</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_51"></A><!-- Hide XML section from browser
<DOC NUMBER=52>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">52 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2008 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Schering AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Merck KGaA</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 30, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">June 14, 2006</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 17, 2007</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">377752</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 17, 2007</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Attitude:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Friendly</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG agreed to acquire a 21.8% minority stake in Schering AG from Merck KGaA for EUR89.36 (US$114.39) per share in cash. Thus, the total consideration for the stake amounts to about EUR3.78 billion (US$4.84 billion). The acquisition allows Bayer AG to go through with its original public offer for Schering AG from March 2006, under which Bayer AG agreed to purchase Schering AG for EUR86 (US$103.1) per share in cash. As a result of the increased offer price for Merck KGaA's 21.8% stake in Schering AG, Bayer AG will withdraw the suit filed against Merck in New York on June 13, 2006. As of November 8, 2006 Bayer AG said it will offer EUR89.36 (US$113.98) a share for nay remaining stakes. Any Schering AG shareholders who don't sell their shares will receive a net annual guaranteed dividend of EUR3.62 (US$4.62) per share. According to a statement by Bayer AG, the company owns as of July 12, 2006 a total of 92.4% in Schering AG. As of 17 January, Bayer AG holds a 96.2% percent stake in Schering AG and plans to squeeze-out the remaining minority shareholders.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BE = 194,200,000 Schering s/o * 21.8% * EUR89.36 = EUR3,767,868,400.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Premium Offered:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0.042</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Owned Before:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">78.200%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">21.800%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$114.001</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$4,754,121,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$4,826,302,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">27.810</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">6.703</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$4,826,301,754</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$4,884,751,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$4,826,302,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Schering AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Over the Counter</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0845K10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures pharmaceuticals and diagnostic substances</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2005</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6,261.171</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1,144.185</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">736.053</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">410.491</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">17.694</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2005</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6,261.171</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1,144.185</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">736.053</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">410.491</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">17.694</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBITDA</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">13.322</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBIT</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">18.029</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$7,198,932,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$915,348,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Long Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,848,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other Short-Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$139,190,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Long-Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$268,943,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other Long Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$37,746,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3,053,914,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$15.726</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">194,200,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3.790</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$107.451</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$108.233</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$110.025</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$15.726</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$44.616</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$43.644</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$38.559</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Citigroup, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Greenhill &amp; Co., Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse (US)</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Merck KGaA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Frankfurterstrasse 250, Darmstadt, 64293 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.6151.72.0</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Dr. Christian Raabe, Chairman</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MRK</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D5357W10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2835 - In-Vitro and In-Vivo Diagnostice Manufacturing Substances</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Morgan Stanley</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">May 13, 2008</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_52"></A><!-- Hide XML section from browser
<DOC NUMBER=53>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">53 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2008 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Ehrfeld Mikrotechnik GmbH</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Technology Services GmbH</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Ehrfeld Mikrotechnik GmbH</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 17, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">September 29, 2004</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">September 29, 2004</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">314654</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Conglomerate</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">September 29, 2004</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Technology Services GmbH, a subsidiary of Bayer AG, acquired the business and assets of Ehrfeld Mikrotechnik GmbH for an undisclosed amount. The acquisition will allow Bayer Technology to offer a full range of services from module development through process and product development to the engineering and construction of entire production units. The company will be renamed Ehrfeld Mikrotechnik BTS GmbH and become a subsidiary of Bayer Technology Services.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ehrfeld Mikrotechnik GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Instruments &amp; Photographic Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops, manufactures and markets microreactor modules</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Technology Services GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PricewaterhouseCoopers AG</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ehrfeld Mikrotechnik GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Mikroforum Ring 1, Wendelsheim, 55234 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.67.3491.9300</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3829 - Measuring &amp; contolling devices, nec </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">April 22, 2008</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_53"></A><!-- Hide XML section from browser
<DOC NUMBER=54>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">54 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2008 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Bayer AG /Natural Substances Division/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG /Natural Substances Division/ /Mgmt &amp; Employees/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 16, 2008</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">April 28, 2006</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 28, 2006</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">373053</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture Unit Management. Leveraged buyout.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Financial</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 28, 2006</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">A private group led by the management and employees of Bayer AG's Natural Substances Division acquired the business and assets of the division for an undisclosed price. The Natural Substances Division of Germany based Bayer AG specializes in the research and development of new products on its own account and for customers in the pharmaceuticals, agrochemicals, and food industries. Following the acquisition, the division will be renamed InterMed Discovery and be located to Dortmund, Germany in mid 2006.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG /Natural Substances Division/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Researches and develops new products on its own account and for customers in the pharmaceuticals, agrochemicals, and food industries</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG /Natural Substances Division/ /Mgmt &amp; Employees/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Wuppertal, Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Led by the management and employees of Bayer AG's Natural Substances Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brokerage, Investment &amp; Management Consultancy</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">6799 - Investors, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8731 - Commercial physical research </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8731 - Commercial physical research </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">March 21, 2008</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_54"></A><!-- Hide XML section from browser
<DOC NUMBER=55>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">55 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2007 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Paragon Seed, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Nunhems BV</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Paragon Seed, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">December 12, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">December 12, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">December 12, 2007</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">450717</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">December 12, 2007</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Nunhems BV, a subsidiary of Bayer CropScience AG, which is part of Bayer AG, acquired Paragon Seed Inc for an undisclosed amount. Paragon Seed Inc is a producer of lettuce, which had sales of $8US.5 million in 2006. With Paragon, Nunhems BV can strengthen its position in the US lettuce seed market.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paragon Seed, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricultural Production</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Breeds, produces and sells lettuce varieties</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2006</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">8.500</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2006</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">8.500</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Nunhems BV</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$82.370</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$84.730</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$86.470</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paragon Seed, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">507 Abbott Street, Salinas, CA 93901 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.831.753.2100</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0161 - Vegetables and melons</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">December 17, 2007</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_55"></A><!-- Hide XML section from browser
<DOC NUMBER=56>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">56 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2007 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Dr. DA Delis AG /Polyurethanes/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Dr. D.A. Delis AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">November 19, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 19, 2007</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">447721</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG, which is a subsidiary of Bayer AG, agreed to acquire the business and assets of Dr DA Delis AG's polyurethanes business for an undisclosed amount. This transaction will increase Bayer MaterialScience AG's stake in the polyurethane manufacturing business in Greece.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Dr. DA Delis AG /Polyurethanes/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Greece</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures polyurethanes</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$81.508</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$80.233</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$79.208</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Dr. D.A. Delis AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paleologou Benizelou 5, Athens, 10556 Greece</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">30.210.329.7222</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2821 - Plastics materials and resins</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">November 23, 2007</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_56"></A><!-- Hide XML section from browser
<DOC NUMBER=57>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">57 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2007 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Oncogene Science, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Siemens Medical Solutions Diagnostics Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">OSI Pharmaceuticals, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">November 15, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 18, 1999</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">December 15, 1999</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">44351</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">December 15, 1999</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer, through its Bayer Diagnostics subsidiary, acquired Oncogene from OSI Pharmaceuticals for $9.75 million in cash plus $1.25 million in contingent payment. The deal will compliment Bayers expertise in commercializing assays across testing platforms.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">(Src Fix-It: Cash)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$11,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$11,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">-2.558</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$9,750,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$11,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contingent Payment Amount:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,250,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Future Payment Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 1, 2001</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$11,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Oncogene Science, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">NASDAQ</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">67104010</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Health Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides cancer diagnostics services</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">09/20/1996</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">15.900</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-4.300</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">09/20/1996</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">15.900</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-4.300</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.730</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">21,890,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$-0.290</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Siemens Medical Solutions Diagnostics Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,235,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,797,900,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.730</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.460</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40.310</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40.700</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42.120</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">OSI Pharmaceuticals, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Uniondale, NY United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.631.962.2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">OSIP</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">67104010</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8071 - Medical laboratories </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8099 - Health and allied services, nec </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">November 20, 2007</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_57"></A><!-- Hide XML section from browser
<DOC NUMBER=58>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">58 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2007 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Brahe as</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">TP Holding as</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">September 10, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">August 27, 2007</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">438130</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">German polymer company Bayer MaterialScience AG, a subsidiary of Bayer AG, agreed to acquire Czech polyurethane maker Brahe as from TP Holding as for an undisclosed amount. The acquisition reflects the increasing importance of the growing markets of Central and Eastern Europe. The transaction is expected to be completed in the fourth quarter in 2007. Bayer and Brahe have been cooperating since the 1960s. Brahe as will be renamed to BaySystems CentralEurope as.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brahe as</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Czech</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Plastics &amp; Rubber</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures polyurethane products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of healthcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$79.201</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$74.177</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$77.325</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">TP Holding as</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Prague, Czech</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3089 - Plastics products, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">September 14, 2007</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_58"></A><!-- Hide XML section from browser
<DOC NUMBER=59>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">59 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2007 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">SeedEx</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">SeedEx</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 13, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">July 13, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 13, 2007</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">430884</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 13, 2007</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, has acquired South Korean vegetable seed company, SeedEx, for an undisclosed amount. SeedEx specializes in the breeding, production and marketing of Hot pepper and Brassica varieties. The acquisition is expected to strengthen Nunhems, a vegetable seed division of Bayer CropScience, by offering access to new Asian markets.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SeedEx</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">South Korea</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of heathcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$72.075</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$77.353</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$77.232</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SeedEx</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">South Korea</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7389 - Business services, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">July 18, 2007</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_59"></A><!-- Hide XML section from browser
<DOC NUMBER=60>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">60 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2007 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Taiwan Ure-Tech Co. Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer MaterialScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Taiwan Ure-Tech Co. Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 2, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 23, 2006</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 1, 2007</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">395365</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 1, 2007</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG, a polymer materials developer and a subsidiary of publicly-listed pharmaceutical and chemical conglomerate Bayer AG, acquired 100% stake in Taiwan Ure-Tech Co Ltd for an undisclosed amount. Based in Taiwan, Ure-Tech is one of the largest thermoplastic polyurethane materials producers in the Asia Pacific region; the company posted sales of approximately TWD 1.8 billion (US$ 55.0 million) in 2005. This acquisition allowed the bidder to become the world's largest supplier and solutions provider of thermoplastic polyurethane resins and films.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Taiwan Ure-Tech Co. Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Taiwan</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures thermoplastic polyurethane materials</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2005</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">55.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2005</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">55.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer MaterialScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures a variety of heathcare and pharmaceutical products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$48.375</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$49.801</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$50.642</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Taiwan Ure-Tech Co. Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chang Hwa Coast Industrial Parki, 8th floor, Chang-Bin East 6th Road, Hsein-Hsi Hsiang, Chang Hwa County, Taiwan</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">886.4.791.0099</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2821 - Plastics materials and resins</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3086 - Plastics foam products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">July 6, 2007</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_60"></A><!-- Hide XML section from browser
<DOC NUMBER=61>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">61 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2007 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Stoneville Pedigreed Seed Co.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer CropScience AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Monsanto Co.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">June 19, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">May 31, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">June 19, 2007</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">424481</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">June 19, 2007</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG, a subsidiary of Bayer AG, acquired Stoneville Pedigreed Seed Co from Monsanto Co for approximately US$310 million. Stoneville Pedigreed Seed, based in Memphis, Tennessee, produces and markets cotton planting seeds. The acquisition is expected to strengthen the position of the rapidly growing US cotton seed business of BayerCropScience.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$310,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$310,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$310,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$310,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Stoneville Pedigreed Seed Co.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">New York Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricultural Production</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Produces and markets cotton planting seeds</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$66.610</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$70.580</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$70.360</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deutsche Bank AG</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Monsanto Co.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">800 North Lindbergh Boulevard, St. Louis, MO 63167 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.314.694.1000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Stephanie Rach, Pacific Group</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MON</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">61166W10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0131 - Cotton</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">JPMorgan Chase &amp; Co., Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 22, 2007</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_61"></A><!-- Hide XML section from browser
<DOC NUMBER=62>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">62 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2007 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">InDEC BV</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / H.C. Starck GmbH &amp; Co. KG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Energy Research Centre of the Netherlands</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">May 11, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 12, 2002</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 1, 2003</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">187929</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Conglomerate</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 1, 2003</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Venture Capital</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">HC Starck Gmbh &amp; Co Kg acquired a majority stake in InDEC BV from the Energy Research Centre of the Netherlands and Planet Capital for an undisclosed amount. HC Starck is a unit of the Bayer AG group.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">( Currency; German Marks : U.S. Dollars 1:0.486609 ) Planet Capital website</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">InDEC BV</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Netherlands (Holland)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Retail</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures ceramic fuel components</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">H.C. Starck GmbH &amp; Co. KG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Energy Research Centre of the Netherlands</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PO box 1, Petten, 1755 ZG Netherlands (Holland)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5989 - Fuel dealers, nec </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3295 - Minerals, ground or treated </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">May 16, 2007</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_62"></A><!-- Hide XML section from browser
<DOC NUMBER=63>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">63 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2007 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Pharmonyx Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer HealthCare AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Pharmonyx Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">February 22, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">February 20, 2007</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">February 20, 2007</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">411911</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Vertical</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">February 20, 2007</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer HealthCare AG, which is a subsidiary of Bayer AG, acquired Pharmonyx Ltd for an undisclosed amount. Since 1999 Pharmonyx Ltd has been both providing marketing services and distributing Bayer HealthCare AG's products in Russia, Belarus, Ukraine, and Kazakhstan. Bayer HealthCare AG will also gain 219 employees from Pharmonyx Ltd as a result of this transaction.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pharmonyx Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Russia</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Wholesale &amp; Distribution</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Wholesales pharmaceuticals and provides marketing services</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer HealthCare AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,916,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$887,175,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.199</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$52.812</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$59.573</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$58.486</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pharmonyx Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Groholsky Per., 13/2, Moscow, 129010 Russia</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7.495.234.2090</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5122 - Drugs, proprietaries, and sundries </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8742 - Management consulting services </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">February 27, 2007</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_63"></A><!-- Hide XML section from browser
<DOC NUMBER=64>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">64 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2006 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Metrika, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Healthcare LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Metrika, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">September 11, 2006</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">July 6, 2006</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 6, 2006</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">379871</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Vertical</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 6, 2006</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer HealthCare LLC, a member of Bayer AG, acquired privately-held Metrika Inc for an undisclosed sum. Based in Sunnyvale, CA, Metrika manufactures and markets A1CNow+(R), a meter-based diabetes monitoring system that has single-use, disposable test cartridges.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Metrika, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and markets diabetes monitoring products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Healthcare LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.111</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$43.350</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$43.110</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$45.380</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Metrika, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">510 Oakmead Parkway, Sunnyvale, CA 94085 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.408.524.2255</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Wilson Sonsini Goodrich &amp; Rosati</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">September 15, 2006</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_64"></A><!-- Hide XML section from browser
<DOC NUMBER=65>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">65 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2006 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Jiangsu Qidong Gaitianli Medicines Co. Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Topsun Technology &amp; Science Co. Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">May 16, 2006</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">May 15, 2006</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">374711</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, the second largest pharmaceutical firm in Europe, agreed to acquire a 54.5% majority stake in Jiangsu Qidong Gaitianli Medicines Co Ltd from Topsun Technology &amp; Science Co Ltd for approximately RMB 1.3 billion (US$ 163.8 million). Based in Jiangsu province, the target is currently a wholly-owned subsidiary of Shanghai-listed pharmaceutical firm Topsun Technology &amp; Science. Qidong Gaitianli is one of the largest over-the-counter medicine producers in China. Bayer will also acquire four of Qidong Gaitianli's OTC brands and related sales departments. This acquisition will allow the bidder to strengthen its pharmaceutical operations in China.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">54.510%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$163,752,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$163,752,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$163,752,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jiangsu Qidong Gaitianli Medicines Co. Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">China</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and distributes medicines</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">D0711211</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.111</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$45.554</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$46.995</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Topsun Technology &amp; Science Co. Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Topsun Building, No. 23 Tangyan Road, Xining High-Tech Dvp. Zone, Xining City, 710075 China</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">86.29.88330835</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">600771</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Y7170Z10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">May 19, 2006</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_65"></A><!-- Hide XML section from browser
<DOC NUMBER=66>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">66 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2006 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Icon Genetics AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Innovation GmbH</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Icon Genetics AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 12, 2006</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">January 11, 2006</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 11, 2006</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">361241</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 11, 2006</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Innovation GmbH, a subsidiary of German pharmaceutical company Bayer AG, acquired Icon Genetics AG for an undisclosed price. Icon Genetics AG is also a German company that specializes in plant engineering technologies and develops processes for the biotechnological production of biopharmaceuticals. The acquisition will strengthen Bayer's activities aimed at producing specific pharmaceutical substances in plants, according to a statement by Dow Jones.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Icon Genetics AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricultural Production</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides plant engineering technologies and develops processes for the biotechnological production of biopharmaceuticals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Innovation GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Geb&auml;ude K 12, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$39.740</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42.901</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42.111</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Icon Genetics AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Briennerstra&szlig;e 12A, Munich, 80333 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0711 - Soil preparation services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2836 - Biological products exc. diagnostic</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">January 17, 2006</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_66"></A><!-- Hide XML section from browser
<DOC NUMBER=67>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">67 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2005 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Aventis Cropscience</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Aventis SA</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 22, 2005</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 2, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">June 3, 2002</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">157261</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">June 3, 2002</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Aventis Cropscience from Aventis SA and Schering AG for EUR7.25 billion (GB&pound;4.5 billion, US$6.6 billion) including the assumption of debt, of which Schering will receive EUR1.5 billion (GB&pound;938.6m, US$1.36bn) for its stake. Under the terms of the deal, Bayer will acquire a 76% stake from Aventis SA, and the remaining 24% stake from Schering AG. Aventis Cropscience will be integrated into Bayer and renamed Bayer Cropscience. The deal was funded by way of a EUR6bn (GB&pound;3.72bn) revolving credit facility lead arranged by Bank of America Securities, Deutsche Bank and JP Morgan.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor list, 8 Oct 01. KW. Sharon added expected close date-25/10/01 per Reuters</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6,638,835,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6,638,835,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6,638,835,150</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6,638,835,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6,638,835,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Aventis Cropscience</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">France</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agricultural Production</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures crop protection products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3,521.422</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3,521.422</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse First Boston, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Freshfields Bruckhaus Deringer</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Hengeler Mueller Weitzel &amp; Wirtz</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Aventis SA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Espace Europeen de l'Entreprise, 16 avenue de l'Europe, Schiltigheim, 67300 France</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">33.01.47.68.07.05</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Juergen Dormann, Chairman</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">AVE</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">80105N10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0119 - Cash grains, nec</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Goldman Sachs &amp; Co.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Morgan Stanley</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">UBS Warburg AG</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Shearman &amp; Sterling LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cravath Swaine &amp; Moore</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">July 27, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_67"></A><!-- Hide XML section from browser
<DOC NUMBER=68>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">68 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2005 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Roche Holding Ltd. /OTC Drugs Unit/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Roche Holding AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">June 16, 2005</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">July 19, 2004</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 1, 2005</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">306436</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 1, 2005</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Roche Holding Ltd's over-the-counter (OTC) drugs unit for US$2.94 billion. The acquisition includes Roche Consumer Health, Roche's stake in a US OTC joint venture with Bayer, and five Roche OTC production sites in Germany, France, Argentina, Morocco and Indonesia. The expanded OTC company will have 6,700 employees in 120 countries and anticipated annual sales of EUR2.4 billion (US$2.95 billion). Bayer expects the acquisition to significantly strengthen its existing position in the OTC drugs market. In addition, Bayer expects annual synergies of EUR100 to 120 million (US$123 to 148 million) from the deal to be realized over the next three years. On the 19th November 2004, the European Union Commission approved Bayer AG's takeover of Roche Holding AG's units.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,940,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,940,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,940,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,940,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Roche Holding Ltd. /OTC Drugs Unit/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures over-the-counter drugs</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Goldman Sachs &amp; Co.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse First Boston, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Clifford Chance US LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pricewaterhouse</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Roche Holding AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Grenzacherstrasse 124, Basel, 4070 Switzerland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">41.61.688.11.11</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jim Goff, Chairman/CEO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">RHHZY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">77119510</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ABI Corporate Finance</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Davis Polk &amp; Wardwell</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pricewaterhouse</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 27, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_68"></A><!-- Hide XML section from browser
<DOC NUMBER=69>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">69 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2005 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Sybron Chemicals Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Corp.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Sybron Chemicals Inc</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 20, 2005</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">August 30, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">October 23, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">52592</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition Tender Offer</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Public Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 23, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Attitude:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Friendly</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Corp, a subsidiary of Bayer AG, acquired Sybron Chemicals for $200.8 million through a cash tender offer. The acquisition strengthens Bayers core businesses and expands its market position in the NAFTA region.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor list, TS. BE = $35.00 per share x 5,737,561 o/s. Closed, ST. (Src Fix-It: Cash)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Premium Offered:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0.250</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$35.000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$200,815,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$200,815,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">152.132</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">25.549</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$200,814,600</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$334,775,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$200,815,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Seller Breakup Fee:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$12,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sybron Chemicals Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">American Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops, produces, and markets specialty chemicals used in the textile wet processing and environmental markets</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1999</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">269.120</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">5.460</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">2.990</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">13.320</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">11.180</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">QUARTERLY RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10Q</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10Q</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">06/30/2000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Prior Year</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">147.130</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">133.660</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6.810</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">9.550</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.960</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">5.630</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6.350</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6.710</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6.200</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">5.520</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">06/30/2000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">282.590</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">2.720</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">1.320</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">12.960</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">11.860</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBITDA</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">12.156</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBIT</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">22.961</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$258,520,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,590,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Long Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$5,700,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Long-Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$125,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other Long Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$7,860,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.370</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5,738,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$0.200</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$23.880</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$28</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$30</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$26,861,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,151,500,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.370</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$41.525</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42.291</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42.466</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ING Barings Group</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Richards Layton &amp; Finger</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cravath Swaine &amp; Moore</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PricewaterhouseCoopers LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sybron Chemicals Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Birmingham Road, PO Box 66, Birmingham, NJ 08011 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Steven Ladin</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SYC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">87090310</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2821 - Plastics materials and resins</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2843 - Surface active agents</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">JPMorgan &amp; Co.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Wolf Block Schorr &amp; Solis-Cohen LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PricewaterhouseCoopers LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_69"></A><!-- Hide XML section from browser
<DOC NUMBER=70>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">70 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2005 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Zeptosens AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Technology Services GmbH</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Zeptosens AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 9, 2005</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 9, 2005</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 9, 2005</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">330451</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 9, 2005</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Technology Services GmbH, a subsidiary of Bayer AG, acquired the Swiss Zeptosens AG in order to strengthen its expertise in the field of highly sensitive detection processes for life sciences. Financial details about the acquisition were not disclosed. Zeptosens AG specializes in the development of microarray systems and detection technologies enabling ultra-sensitive analysis of biomolecules. The company's microarray systems are used by both the pharmaceutical industry and universities for genome and proteome research.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Zeptosens AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Switzerland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Instruments &amp; Photographic Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops and commercializes microarray systems and detection technologies enabling ultra-sensitive analysis of biomolecules</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Technology Services GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31.243</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$35.707</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$35.284</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Zeptosens AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Benkenstrasse 254, Witterswil, 4108 Switzerland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">41.61.726.81.81</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3826 - Analytical instruments </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8731 - Commercial physical research </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_70"></A><!-- Hide XML section from browser
<DOC NUMBER=71>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">71 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2005 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Worldwide Polyols Business</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Polymers LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Lyondell Chemical Co.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 11, 2005</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 16, 1999</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 3, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">44270</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 3, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer acquired the worldwide polyols business of Lyondell Chemical for $2.45 billion to help boost profit at its largest division. The acquisition includes operations in West Virginia, Texas, Belgium, France, Indonesia, and Taiwan. Lyondell will use the proceeds to reduce debt.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closed by AT. CCN Matthews, AT.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,450,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,450,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,450,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,450,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Worldwide Polyols Business</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures polyols</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Polymers LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,235,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,797,900,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.460</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40.950</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$41.070</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse First Boston, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ivins Phillips &amp; Barker</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cravath Swaine &amp; Moore</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Lyondell Chemical Co.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1221 McKinney Street, Suite 700, Houston, TX 77010-2006 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jackie Wilson</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">LYO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">55207810</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2821 - Plastics materials and resins</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Schroder Salomon Smith Barney</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Baker Botts LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">White &amp; Case LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PricewaterhouseCoopers LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_71"></A><!-- Hide XML section from browser
<DOC NUMBER=72>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">72 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2004 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Bayers AG /Allergy Production Unit/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayers AG /Allergy Production Unit/ /Management/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 12, 2004</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 3, 1999</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 3, 1999</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">36820</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture Unit Management. Leveraged buyout.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Financial</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 3, 1999</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">A private group led by the management of Bayers Allergy Production Unit acquired the companys division for an undisclosed amount.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closed, JWC.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayers AG /Allergy Production Unit/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures allergy immunotherapy and treatment products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayers AG /Allergy Production Unit/ /Management/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7389 - Business services, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_72"></A><!-- Hide XML section from browser
<DOC NUMBER=73>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">73 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2004 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">DSM NV /Transparent Sheet Business/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">DSM NV</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 5, 2004</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">February 5, 1999</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 1, 1999</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">112358</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 1, 1999</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, Germany, the manufacturer and wholesaler of pharmaceuticals, acquired the transparent sheet business including manufacturing facilities at Tielt, Belgium and Sheffield, Massachusetts, US, of DSM, Belgium. Terms not disclosed.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">DSM NV /Transparent Sheet Business/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Netherlands (Holland)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$33,837,059,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,892,919,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">DSM NV</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Het Overloon 1, Heerlen, 6411 TE Netherlands (Holland)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">31.45.578.81.11</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Peter AFW Elverding, Chairman</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">DSMKY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">23332H20</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7389 - Business services, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_73"></A><!-- Hide XML section from browser
<DOC NUMBER=74>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">74 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2004 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Gustafson LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Cropscience India Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Gustafson LLC</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">May 13, 2004</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 22, 2004</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 31, 2004</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">268704</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 31, 2004</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience LP, a subsidiary of Bayer CropScience, itself a subsidiary of Bayer AG, agreed to acquire the 50% stake in Gustafson LLC owned by Crompton Corp for US$124 million in cash. Gustafson manufactures and markets seed treatment products and related equipment. It employs approximately 250 people and generated revenue of approximately US$130 million in 2003. The acquisition gives Bayer CropScience, which already holds a 50% share of Gustafson, full ownership of the seed treatment business in the US, Canada, and Mexico.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closed by GK</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Owned Before:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">50.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">50.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$124,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$124,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$124,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$124,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$124,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Gustafson LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures crop protection products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2003</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">130.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2003</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">130.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Cropscience India Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Fraser Milner Casgrain LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PricewaterhouseCoopers LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Gustafson LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1400 Preston Road, Suite 400, Plano, TX 75093 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_74"></A><!-- Hide XML section from browser
<DOC NUMBER=75>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">75 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2004 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">ABS engineering plastics businesses</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Monsanto Co. /Old/</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 14, 2004</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 15, 1995</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">December 29, 1995</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">18992</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">December 29, 1995</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired ABS engineering plastics businesses. through Monsanto Co. Consideration $580.00M.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$580,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$580,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$580,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$580,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ABS engineering plastics businesses</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Plastics &amp; Rubber</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Mfgs. styrenic plastics.</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">69,300,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Monsanto Co. /Old/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">800 North Lindbergh Boulevard, St. Louis, MO 63167 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.314.694.1000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">71708110</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3089 - Plastics products, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Morgan Grenfell &amp; Co Ltd</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_75"></A><!-- Hide XML section from browser
<DOC NUMBER=76>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">76 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2004 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Corporacion Bonima</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">McKesson Corp.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 14, 2004</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">August 21, 1995</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">August 21, 1995</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">18038</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">August 21, 1995</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired 97% of Corporacion Bonima S.A. de CV through McKesson Corp. Consideration $40.00M.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">(Src Fix-It: Cash)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">97.900%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Corporacion Bonima</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">El Salvador</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Product Line Not Found</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">69,300,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">McKesson Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1 Post Street, San Francisco, CA 94104 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.415.983.8300</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">William R Graber, Senior VP/CFO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MCK</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">58155Q10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Parent NYS:MCK</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_76"></A><!-- Hide XML section from browser
<DOC NUMBER=77>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">77 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2004 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Pau Seeds Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Aventis Cropscience</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Pau Seeds Inc</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 8, 2004</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">December 10, 2002</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">December 10, 2002</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">250336</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">December 10, 2002</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer CropScience, a unit of Bayer AG, acquired an undisclosed controlling interest in Pau Seeds for an undisclosed price. This acquisition includes four active breeding programs and three research stations in the United States.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pau Seeds Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Produces innovative crop science used for crop protection, biotechnology and seed markets</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Aventis Cropscience</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pau Seeds Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Boone, IA United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_77"></A><!-- Hide XML section from browser
<DOC NUMBER=78>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">78 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Sewon Enterprise Co Ltd</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Sewon Enterprise Co Ltd</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">September 19, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">June 29, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">June 29, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">128257</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">June 29, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Sewon Enterprise Co. Ltd, for an undisclosed price. Sewon Enterprise Co. Ltd will be trading under the name Bayer Sewon Ltd. in Kimhae, Pusan. Sewons product portfolio primarily includes solid sheets made from polycarbonate (PC), but also encompasses polymethyl methacrylate (PMMA) and polyvinyl chloride (PVC) sheet. Sewon Enterprise Co. Ltd. posted sales of EUR 18m (GB&pound; 11.24m) in 1999 and has approximately 60 employees. Prior to the transaction Sewon Enterprise Co Ltd was a privately owned company.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sewon Enterprise Co Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">South Korea</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paper</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures plastic sheets</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$26,861,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,151,500,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sewon Enterprise Co Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">South Korea</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2671 - Paper coated &amp; laminated, packaging</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_78"></A><!-- Hide XML section from browser
<DOC NUMBER=79>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">79 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Pursell Industries Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Pursell Industries Inc</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">September 8, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 6, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 9, 1999</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">218322</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 9, 1999</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Pursell Industries for an undisclosed amount. The combined company will offer consumers an extended line of fertilizers and garden products under the Bayer name. Pursell has strong experience in consumer markets and holds a respected position in the US lawn and garden segment. This acquisition marks Bayers entrance into the $1.3 billion market for pesticides and with the combined strengths of Bayer and Pursell, consumers will gain the best products available.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pursell Industries Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Makes fertilizers for lawn, garden, and food plants</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,686,221,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,659,765,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pursell Industries Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">201 4th St W, Sylacauga, AL United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.256.249.1810</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2873 - Nitrogenous fertilizers</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2874 - Phosphatic fertilizers</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_79"></A><!-- Hide XML section from browser
<DOC NUMBER=80>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">80 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Brazilian Diagnostics Division</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Merck KGaA</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">September 3, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">August 6, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">August 6, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">108916</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">August 6, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired the Brazilian diagnostics division of Merck KGaA for an undisclosed price.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazilian Diagnostics Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures diagnostic pharmaceuticals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,686,221,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,659,765,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Merck KGaA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Frankfurter Strasse 250, Darmstadt, 64293 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.6151.72.0</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Dr. Christian Raabe, Chairman</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">58934210</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_80"></A><!-- Hide XML section from browser
<DOC NUMBER=81>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">81 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Bayer Sankyo Co</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Sankyo Co. Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">August 6, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 19, 1999</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 19, 1999</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">112986</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 19, 1999</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, Germany, acquired the remaining 55% stake which it did not already own in Bayer-Sankyo Co, from Sankyo Co Ltd (45%) and Ono Pharmaceutical (10%), for an undisclosed price.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Owned Before:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">45.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">55.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Sankyo Co</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Japan</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Operates a diagnostics company</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$33,837,059,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,892,919,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sankyo Co. Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3-5-1 Nihonbashi-Honcho, Chuo-Ku, Tokyo, 103-8426 Japan</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Tetsuo Takato, President</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">4501</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">J6782210</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_81"></A><!-- Hide XML section from browser
<DOC NUMBER=82>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">82 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Pbi Home &amp; Garden</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Sumitomo Corp.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">August 5, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 8, 1999</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 8, 1999</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">113043</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Conglomerate</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 8, 1999</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired pbi Home &amp; Garden from Sumitomo Corporation for an undisclosed price.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pbi Home &amp; Garden</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Makes garden products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$33,837,059,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,892,919,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cameron Mckenna</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sumitomo Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8-11 Harumi 1-Chome, Chuo-Ku, Tokyo, 104-8610 Japan</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">81.3.5166.5000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Motoyuki Oka, President/CEO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SSUMY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">86561310</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7699 - Repair services, nec </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Livingstone Guarantee PLC</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Denton Hall</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_82"></A><!-- Hide XML section from browser
<DOC NUMBER=83>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">83 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Laserlite Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Impack Pratama Industri</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">August 4, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 11, 1999</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 11, 1999</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">210278</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Conglomerate</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 11, 1999</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Laserlite Inc from Impack Pratama Industri for an undisclosed amount. The move was a part of Bayers global expansion program and also represents its desire to strengthen its polycarbonate sheet business. In 1998, Laserlite reported revenues of AU$28.5 million.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Laserlite Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Australia</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paper</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufacturer of plastic sheeting for the roofing industry</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1998</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">17.638</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1998</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">17.638</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$33,837,059,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,892,919,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Impack Pratama Industri</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Graha Kirana 11th Floor, Jl. Yos Sudarso no.88, Jakarta, 14350 Indonesia</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2671 - Paper coated &amp; laminated, packaging</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_83"></A><!-- Hide XML section from browser
<DOC NUMBER=84>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">84 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Makroform GmbH</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Makroform GmbH</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">August 4, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">July 25, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 25, 2003</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">208620</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 25, 2003</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG announced its acquisition of the remaining 45.5% interest in Makroform GmbH, a joint venture that was originally formed in 2000 between Bayer AG and Roehm GmbH, a subsidiary of Degussa AG. Terms of the transaction were not disclosed. The acquisition will enable Bayer Polymers, a subgroup of Bayer AG, to strengthen its position as a leading manufacturer of polycarbonate plastic sheeting.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Owned Before:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">54.500%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">45.500%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Makroform GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Plastics &amp; Rubber</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Produces Polycarbonate and Polyester sheets</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PWC Deutsche Revision</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Makroform GmbH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Dolivostr., Darmstadt, 64293 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pierre E. Colle, CEO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3081 - Unsupported plastics film &amp; sheet</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_84"></A><!-- Hide XML section from browser
<DOC NUMBER=85>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">85 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">ABS Industries, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Industries</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">ABS Industries, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 1, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 1, 1996</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">October 1, 1996</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">96053</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 1, 1996</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer, through its subsidiary Bayer Industries, acquired a 51% stake in ABS Industries for R641 million.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">51.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$18,065,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$18,065,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$18,065,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$18,065,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ABS Industries, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Over the Counter</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufacturer of plastics</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">09/20/1995</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">92.120</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">4.850</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">09/20/1995</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">92.120</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">4.850</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3.270</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">5,050,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$0.980</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Industries</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,493,346,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,680,932,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3.270</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ABS Industries, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PO Box 630, Willoughby, OH 44096-0630 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.216.946.2274</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ABSI</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">00078110</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2821 - Plastics materials and resins</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_85"></A><!-- Hide XML section from browser
<DOC NUMBER=86>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">86 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Technical Films Business of Elf Atochem Deutschland</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Elf Atochem</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">June 30, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">April 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 1, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">105939</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 1, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer, Germany, acquired the technical films business in Germany of Elf Atochem Deutschland, Germany, from Elf Atochem, France. Terms not disclosed.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Technical Films Business of Elf Atochem Deutschland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Instruments &amp; Photographic Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufacturer of technical films</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,686,221,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,659,765,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Elf Atochem</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">4 Cours Michelet, Paris, 92800 France</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3861 - Photographic equipment and supplies </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_86"></A><!-- Hide XML section from browser
<DOC NUMBER=87>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">87 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Paltough</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Kibbutz Ramat Yohanan</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">May 15, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">May 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">May 1, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">106615</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Unit Minority</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">May 1, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired a 20% minority stake in Paltough from Kibbutz Ramat Yohanan for an undisclosed price.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">20.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paltough</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Israel</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Plastics &amp; Rubber</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures corrugated sheets</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,686,221,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,659,765,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Kibbutz Ramat Yohanan</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Israel</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3081 - Unsupported plastics film &amp; sheet</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_87"></A><!-- Hide XML section from browser
<DOC NUMBER=88>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">88 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Polygal</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Kibbutz Ramat Hashofet / Megiddo</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">May 15, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">May 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">May 1, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">106614</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Unit Minority</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">May 1, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired a 25% minority stake in Polygal from Kibbutz Ramat Hashofet and Megiddo for an undisclosed price.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">25.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Polygal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Israel</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paper</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures polycarbonate and polypropylene sheets</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,686,221,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,659,765,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Kibbutz Ramat Hashofet / Megiddo</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Israel</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2671 - Paper coated &amp; laminated, packaging</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3081 - Unsupported plastics film &amp; sheet</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_88"></A><!-- Hide XML section from browser
<DOC NUMBER=89>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">89 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Iron Oxide Pigment Business of W Hawley &amp; Son Lt</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">W Hawley &amp; Son Ltd</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">May 14, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">May 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">May 1, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">106433</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">May 1, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired the iron oxide pigment business of W Hawley &amp; Son Ltd, for an undisclosed price.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">(CPN: /M EWCUW)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Iron Oxide Pigment Business of W Hawley &amp; Son Lt</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures iron oxide pigments</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,686,221,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,659,765,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">W Hawley &amp; Son Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Colour Works, Duffield, Derby, DE56 4FG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_89"></A><!-- Hide XML section from browser
<DOC NUMBER=90>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">90 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Misung Ltd</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Aventis SA</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 30, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 1, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 1, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">123823</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 1, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired the remaining 50.1% stake that it did not already own in Misung Ltd, a crop-protection chemicals manufacturing joint venture, from its joint venture partner Aventis CropScience, the agro-chemicals subsidiary of Aventis SA, for an undisclosed amount.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Owned Before:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.900%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">50.100%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Misung Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">South Korea</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures crop protection chemicals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,092,350,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,040,936,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.740</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Aventis SA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Espace Europeen de l'Entreprise, 16 avenue de l'Europe, Schiltigheim, 67300 France</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">33.01.47.68.07.05</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Juergen Dormann, Chairman</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Joint Venture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">AVE</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">80105N10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_90"></A><!-- Hide XML section from browser
<DOC NUMBER=91>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">91 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">ChemConnect, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">ChemConnect, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 22, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 1, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 1, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">124253</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture Minority Interest</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Vertical</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 1, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired a minority stake in ChemConnect Inc for an undisclosed amount.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">-1.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ChemConnect, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Internet; Computer Software, Supplies &amp; Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides market information &amp; e-commerce solutions</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,092,350,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,040,936,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.740</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ChemConnect, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2900 North Loop West, Suite 1210, Houston, TX 77092 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.713.470.2450</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">John F. Beasley</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7375 - Information retrieval services </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7389 - Business services, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_91"></A><!-- Hide XML section from browser
<DOC NUMBER=92>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">92 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Nannau Ltd</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Pan Britannica Industries Ltd</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Scotts Company LLC</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 17, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">February 1, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">February 1, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">123345</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">February 1, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PBI Home &amp; Garden Ltd acquired Phostrogen Ltd from The Scotts Company of the US for US$6.4 million (GB&pound;4.0 million). PBI Home &amp; Garden is a subsidiary of Bayer Plc, which itself is a division of Bayer AG, the German chemicals company.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6,508,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6,508,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">403.000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3.731</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6,508,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6,508,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Nannau Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and sells plant foods and associated garden and houseplant products to wholesalers, retailers, professional growers</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">09/30/1998</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.017</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.017</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">09/30/1998</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.017</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.017</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBIT</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">403</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,968,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,817,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pan Britannica Industries Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,092,350,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,040,936,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.740</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Scotts Company LLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">14111 Scottslawn Road, Marysville, OH 43041 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Rebecca Bruening, Exec VP/CFO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SCTT</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">90212410</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2873 - Nitrogenous fertilizers</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Arthur Andersen LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_92"></A><!-- Hide XML section from browser
<DOC NUMBER=93>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">93 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">PPL Therapeutics PLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">PPL Therapeutics PLC</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 15, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">September 1, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">September 1, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">132891</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture Minority Interest</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">September 1, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired an undisclosed stake in PPL Therapeutics for GB&pound;10.2 million (US$14.9 million). Under the terms of the deal, Bayer AG acquired an undisclosed amount of shares at 215 pence each in PPL Therapeutics and will fund the development of a product which can be used against cystic fibrosis and genetic lung disease.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">(CPN: /G 2.0) (CPN: /H -38.8) (CPN: /M GAFTW)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">-1.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,895,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,895,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,895,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,895,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PPL Therapeutics PLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">London Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures pharmaceutical products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1999</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.783</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-23.084</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-23.084</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.789</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.352</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1999</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.783</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-23.084</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-23.084</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.789</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.352</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$47,654,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$687,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other Short-Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$687,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other Long Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,455,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42,939,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$26,861,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,151,500,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PPL Therapeutics PLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Roslin, Edinburgh, EH25 9PP</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">44.131.4404777</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PTH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">G7207U10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">6719 - Holding companies, nec </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CMS Cameron McKenna</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_93"></A><!-- Hide XML section from browser
<DOC NUMBER=94>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">94 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">CSM Industries Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / HC Starck Gmbh &amp; Co Kg</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">CSM Industries Inc</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 18, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 18, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 30, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">133322</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 30, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">HC Starck GmbH &amp; Co KG, a subsidiary of Bayer AG, acquired CSM Indsustries Inc for an undisclosed amount. HC Starck GmbH &amp; Co KG produces metal and ceramic powders as well as wire and mill products for a broad range of uses.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CSM Industries Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Metal Processing</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures specialty metals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">HC Starck Gmbh &amp; Co Kg</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Reuters Update</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$26,861,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,151,500,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CSM Industries Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cleveland, OH United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">William Steinbrink</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3356 - Nonferrous rolling and drawing, nec </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Reuters Update</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Piper Jaffray, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_94"></A><!-- Hide XML section from browser
<DOC NUMBER=95>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">95 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Novartis Agribusiness /Flint Fungicide Business/</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Crop Protection</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Novartis AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 18, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 1, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">October 1, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">134175</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 1, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Crop Protection, the agribusiness division of Bayer AG, acquired the FLINT fungicide business, including the production facilities in Muttenz, Switzerland, as well as associated property rights, of Novartis Crop Protection, the agribusiness division of Novartis AG, for CHF1.3 billion (US$753.4 million). FLINT is a second-generation strobilurin fungicide with a broad spectrum of applications.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$752,123,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$752,123,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$752,123,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$752,123,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Novartis Agribusiness /Flint Fungicide Business/</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Switzerland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Produces fungicide</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Crop Protection</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$26,861,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,151,500,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Novartis AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Lichtstra&szlig;e 35, Basel, 4056 Switzerland</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">41.61.324.11.11</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Raymond Breu, CFO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">NVS</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">66987V10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Shearman &amp; Sterling LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_95"></A><!-- Hide XML section from browser
<DOC NUMBER=96>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">96 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Hughes Industrial Corp</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Corp.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Hughes Industrial Corp</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 13, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">June 20, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">June 20, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">50493</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">June 20, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Corp, a subsidiary of Bayer AG, acquired Hughes Industrial of Kennesaw, Georgia, for an undisclosed amount in a move to expand its product line to offer a broad range of chemical blowing agents which are used mainly in rigid PVC foam applications.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Hughes Industrial Corp</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures chemical blowing agents for rigid PVC foam applications</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$26,861,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,151,500,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40.170</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40.710</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$38.290</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Hughes Industrial Corp</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1650 Airport Road NW, Kennesaw, GA 30144 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_96"></A><!-- Hide XML section from browser
<DOC NUMBER=97>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">97 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Paper Sizing &amp; Strength Business</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Corp.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Cytec Industries, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 6, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">September 5, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 1, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">52518</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 1, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer acquired the paper chemicals sizing and strength business of Cytec Industries for $90 million in cash to enhance its products. The acquisition complements its strong US market position in colorants and optical brighteners.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closed, GV. (Src Fix-It: Cash)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$90,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$90,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$90,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$90,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$90,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paper Sizing &amp; Strength Business</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops, manufactures, and markets specialty chemicals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$26,861,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,151,500,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40.722</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42.466</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$41.817</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deutsche Bank Alex Brown, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PricewaterhouseCoopers LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cytec Industries, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Five Garrett Mountain Plaza, West Paterson, NJ 07424 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">James P Cronin, Exec VP/CFO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CYT</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">23282010</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2869 - Industrial organic chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse First Boston, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cravath Swaine &amp; Moore</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">KPMG Peat Marwick LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_97"></A><!-- Hide XML section from browser
<DOC NUMBER=98>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">98 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Avigen, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Avigen, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">February 27, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 17, 2000</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 17, 2000</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">141323</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture Minority Interest</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 17, 2000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, acquired a 2.5% stake in Avigen Inc, for US$15m (GB&pound;10.3m). The deal is part of a US$60m (GB&pound;41.2m) agreement to grant Bayer worldwide marketing and distribution rights for Avigens Coagulin-B gene therapy treatment for hemophilia B.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2.500%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,911,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,911,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,911,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,911,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Avigen, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">NASDAQ</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops gene therapy products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$26,861,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2,151,500,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Avigen, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1301 Harbor Bay Parkway, Suite 1000, Alameda, CA 94502 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">AVGN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">05369010</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8731 - Commercial physical research </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_98"></A><!-- Hide XML section from browser
<DOC NUMBER=99>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">99 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2003 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Visible Genetics Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Diagnostics Corp.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Visible Genetics Inc</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 30, 2003</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">July 23, 2002</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">October 10, 2002</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">175154</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 10, 2002</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Diagnostics, a division of Bayer AG, acquired Visible Genetics for $CDN43.7 million in cash (US$28.8 million). This acquisition is consistent with the strategy of Bayer Diagnostics to expand its Infectious Disease portfolio and strengthen its position within the nucleic acid diagnostic segment of the professional laboratory market. In addition, this acquisition will enable Visible Genetics to develop and grow its sequencing technology. Visible Genetics has 350 employees.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BE= $1.50 per share x 19,197,191 o/s. Advisor list, 15 Oct 02, KW.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Premium Offered:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0.916</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.502</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$28,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$28,780,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">-0.662</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0.493</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$28,780,116</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$57,402,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$28,780,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Visible Genetics Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Canada</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">NASDAQ</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Instruments &amp; Photographic Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and markets automated DNA sequencing systems and diagnostic kits</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/2001</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">13.580</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-40.654</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-40.654</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">7.722</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.008</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">QUARTERLY RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10Q</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10Q</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">06/30/2002</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Prior Year</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">8.989</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">7.502</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-20.804</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-17.948</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-20.804</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-17.948</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.198</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">2.087</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.003</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.002</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">06/30/2002</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">15.067</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-43.510</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-43.510</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">8.833</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.009</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBITDA</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">-1.658</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital/EBIT</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">-1.322</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$76,408,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,189,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Preferred Stock (par)</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$28,667,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$58,516,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3.048</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">19,197,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$-2.267</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1.976</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$0.784</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$0.777</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Diagnostics Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3.048</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse First Boston, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PWC Deutsche Revision</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Visible Genetics Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">700 Bay Street, Suite 1000, Box 333, Toronto, MSG 126 Canada</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Thomas Clarke, CFO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">VGIN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">92829S10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3826 - Analytical instruments </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8731 - Commercial physical research </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bear, Stearns &amp; Co., Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brown Raysman Millstein Felder &amp; Steiner LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_99"></A><!-- Hide XML section from browser
<DOC NUMBER=100>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">100 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2002 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Polyurethanes Activities of Tectrade AS</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Tectrade AS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">November 13, 2002</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 25, 2002</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 31, 2002</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">171795</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 31, 2002</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, Leverkusen, Nordrhein-Westfalen (North Rhine-Westphalia), Germany, a research-based company with major businesses in healthcare, agriculture, polymers and chemicals, will acquire the polyurethanes activities of Tectrade A/S, Vedbaek (Copenhagen), Denmark, a supplier of machines and turn key production plants for the polyurethane processing industry.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">( Currency; German Marks : U.S. Dollars 1:0.441481 )</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Polyurethanes Activities of Tectrade AS</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Denmark</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Plastics &amp; Rubber</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops polyurethane formulations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Tectrade AS</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Koning Albert I-Laan 122, Brugge, 8200 Denmark</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3086 - Plastics foam products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_100"></A><!-- Hide XML section from browser
<DOC NUMBER=101>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">101 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2002 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Aliphatic Diisocyanates Business of Lyondell Chemical Co</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Lyondell Chemical Co.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 29, 2002</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">December 20, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">December 31, 2001</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">157554</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">December 31, 2001</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer acquired the assets of the aliphatic diisocyanates business of Lyondell Chemical for an undisclosed amount. The aliphatic isocyanate products include hexamethylene diisocyanate, isophore diisocyanate, and aliphatic polyisocyanates, which are used to manufacture polyurethane coatings.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Aliphatic Diisocyanates Business of Lyondell Chemical Co</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures and markets intermediate chemicals and performance chemical products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jones Day</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Lyondell Chemical Co.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1221 McKinney Street, Suite 700, Houston, TX 77010-2006 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Jackie Wilson</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">LYO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">55207810</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2869 - Industrial organic chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PricewaterhouseCoopers LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_101"></A><!-- Hide XML section from browser
<DOC NUMBER=102>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">102 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2001 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">PPL Therapeutics Scotland Ltd.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">PPL Therapeutics Scotland Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 16, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">July 13, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 13, 2001</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">151677</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture Minority Interest</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 13, 2001</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, Leverkusen, Nordrhein-Westfalen (North Rhine-Westphalia), Germany, a manufacturer of chemicals, acquired a further 16% stake in PPL Therapeutics Ltd, Roslin, Midlothian, Scotland, a company engaged in the bio-production of commercially valuable protiens. Under the terms of the deal Bayer AG is guaranteeing a GB&pound;15m bank loan, from Royal Bank of Scotland, to PPL Therapeutics.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">16.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$21,096,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$21,096,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$21,096,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$21,096,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PPL Therapeutics Scotland Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bio-production of commercially valuable proteins</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1995</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6.826</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-2.080</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-2.080</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.462</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.092</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1995</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6.826</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-2.080</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-2.080</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.462</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.092</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$26,332,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$8,597,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6,579,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PPL Therapeutics Scotland Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Roslin, Midlothian, Scotland, EH25 9PP</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_102"></A><!-- Hide XML section from browser
<DOC NUMBER=103>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">103 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2001 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Corporacion Bonima</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Generic Holding Gmbh</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">McKesson Corp.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 25, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">August 1, 1995</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">August 1, 1995</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">88971</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">August 1, 1995</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Generic Holding GmbH, Germany, a pharmaceuticals manufacturer and subsidiary of Bayer AG, acquired Corporacion Bonima, El Salvador, a pharmaceuticals manufacturer, from McKesson. Consideration $40m (&pound;25.52m).</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$39,991,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$39,991,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$39,991,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$39,991,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Corporacion Bonima</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">El Salvador</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Product Line Not Found</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Generic Holding Gmbh</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$28,389,126,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,280,435,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">McKesson Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1 Post Street, San Francisco, CA 94104 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.415.983.8300</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">William R Graber, Senior VP/CFO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">MCK</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">58155Q10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">JPMorgan &amp; Co.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_103"></A><!-- Hide XML section from browser
<DOC NUMBER=104>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">104 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2001 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Globo SA Tintas e Pigmentos</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Sherwin Williams Co/Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Reckitt Benckiser PLC</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 25, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">July 22, 1996</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 22, 1996</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">3190</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 22, 1996</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">This was a joint-acquisition between Sherwin-Williams and Bayer S.A., the Brazilian subsidiary of Bayer A.G. Consideration US$93.36m (GB60.1m pounds sterling) in cash.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$93,360,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$93,360,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$93,360,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$93,360,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$93,360,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Globo SA Tintas e Pigmentos</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Makes and sells paints and pigments</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sherwin Williams Co/Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">101 Prospect Avenue NW, Cleveland, OH 44115 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Makes coatings and operates paint stores</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2851 - Paints and allied products</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2816 - Inorganic pigments</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$3,273,800,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$200,700,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">85,632,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.350</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$44.880</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$46.380</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$44.380</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LEGAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Slaughter &amp; May</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ernst &amp; Young LLP</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Reckitt Benckiser PLC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">103 - 105 Bath Road, Slough, SL1 3UH</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">44.17.5321.7800</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Patricia Jones, CFO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">RB.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">G7422310</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2851 - Paints and allied products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_104"></A><!-- Hide XML section from browser
<DOC NUMBER=105>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">105 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2001 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Graphic Film &amp; Offset Print Business</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Agfa Gevaert AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">DuPont - E.I. du Pont de Nemours &amp; Co.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 25, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">May 22, 1997</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 5, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">21843</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 5, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AGs Agfa-Gevaert acquired the Graphic Film and Offsett Printing Plate Business of Du Pont but did not disclose financial terms of the deal.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Graphic Film &amp; Offset Print Business</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Graphic film and offset printing services</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">08/22/1996</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">532.500</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">08/22/1996</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">532.500</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agfa Gevaert AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,832,252,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,770,213,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$40.130</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$38.380</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 1 Day Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$38.380</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">DuPont - E.I. du Pont de Nemours &amp; Co.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1007 Market Street, Wilmington, DE 19898 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Gary M Pfeiffer, Senior VP/CFO</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">DD</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">26353410</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7384 - Photofinishing laboratories </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Located at Neu Isenburg, Germany and Leeds, Margate and Thetford, Great Britain.</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Credit Suisse First Boston, Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_105"></A><!-- Hide XML section from browser
<DOC NUMBER=106>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">106 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2001 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Schein Pharmaceutical, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Miles Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Schein Pharmaceutical, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 25, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">February 18, 1994</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">October 19, 1994</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">13077</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture Minority Interest</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 19, 1994</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG through Miles Inc. acquired 28% of Schein Pharmaceutical Inc. Consideration $310.00M.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">28.300%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$310,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$310,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$310,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$310,000,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Schein Pharmaceutical, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">New York Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Healthcare; Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Develops, manufactures, and markets generic pharmaceuticals, including soid dosage and sterile dosage products</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">05/18/1993</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">400.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">05/18/1993</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">400.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miles Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Schein Pharmaceutical, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100 Campus Drive, Florham Park, NJ 07932 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Whitney Sterans</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">SHP</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">94268310</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL ADVISORS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Fee ($m)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bear, Stearns &amp; Co., Inc.</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Advisor</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_106"></A><!-- Hide XML section from browser
<DOC NUMBER=107>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">107 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2001 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Innogenetics NV</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Innogenetics NV</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 16, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 15, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 15, 2001</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">142311</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture Minority Interest</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 15, 2001</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, Leverkusen, Nordrhein-Westfalen (North Rhien Westphalia), Germany, a research based company active in the healthcare, agriculture, polymers and speciality chemicals group, acquired a stake of approximately 2% in Innogenetics NV, Zwijnaarde, Belgium, a biotechnology group. Consideration Euro10m (GB&pound;6.34m). At the same time, Bayer also acquired the exclusive worldwide sale and marketing rights of LiPA HIV and LiPA HCV products, two diagnostics products developed by Innogenetics, to diagnose sufferers of the HIV virus and Hepatitis C respectively, for an initial price of Euro10.4m (GB&pound;6.59m). Bayer agreed to pay a future milestone payment of an undisclosed sum, plus research and development funding for the products over the next five years, and will pay Innogenetics a percentage of the sale price.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$9,222,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$9,222,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$9,222,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$9,222,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Innogenetics NV</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Belgium</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides commercial physical and biological research</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1998</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">30.860</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-8.769</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-8.769</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.226</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.067</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1998</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">30.860</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-8.769</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-8.769</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">3.226</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">0.067</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$112,026,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$33,640,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Long-Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$467,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$89,667,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Innogenetics NV</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Technologie Park 6, Gent, 9052 Belgium</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">32.9.329.13.29</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">INNX</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">B5078Q10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8731 - Commercial physical research </SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_107"></A><!-- Hide XML section from browser
<DOC NUMBER=108>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">108 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 2001 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Curagen Corp.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Curagen Corp.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 17, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">January 17, 2001</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 17, 2001</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">137826</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture Minority Interest</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 17, 2001</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, Leverkusen, Nordrhein-Westfalen (North Rhine-Westphalia), Germany, the research-based company with major businesses in health care, agriculture, polymers and specialty chemicals, acquired a 7% stake CuraGen Corporation, New Haven, CT, USA, a company involved in the development of pharmaceutical and life science products through the systematic application of genomics, as part of an expandable, five-year pharmacogenomic and toxicogenomic collaboration between the two companies. Total consideration US$ 124m (GB&pound; 83.07m) , which includes US$ 85m (GB&pound; 56.94m) for the 7% equity investment in CuraGen by Bayer AG and US$39m (GB&pound; 26.13m) in committed funding to CuraGen. Bayer AG and CuraGen Corporation also formed an obesity and diabetes alliance.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$124,090,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$124,090,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$124,089,966</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$124,090,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$124,090,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Curagen Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">NASDAQ</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Product Line Not Found</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$13,823,128,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$822,130,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">730,342,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">EPS, Latest 12 Months *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$2.490</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Curagen Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">555 Long Wharf Drive, New Haven, CT CT 06511 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CRGN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">23126R10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7389 - Business services, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_108"></A><!-- Hide XML section from browser
<DOC NUMBER=109>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">109 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1998 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Monotype Typography Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Agfa-Gevaert NV</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Monotype Typography Inc</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">July 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 1, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">108284</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 1, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agfa Gevaert NV, Mortsel, Belgium, the photographic and electronic imaging subsidiary of Bayer AG, Germany, the chemicals group, acquired Monotype Typography Inc, Chicago, US, the producer of software for computers and peripherals. Under the terms of the deal, Monotype Typography Inc will continue its worldwide business activities under its own name and under the same management. Terms not disclosed.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Monotype Typography Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Computer Software, Supplies &amp; Services</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Product Line Not Found</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agfa-Gevaert NV</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,686,221,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,659,765,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Monotype Typography Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7371 - Computer programming services </SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_109"></A><!-- Hide XML section from browser
<DOC NUMBER=110>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">110 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1998 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">San</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Nitriflex</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">April 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">April 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 1, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">105940</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 1, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer, Germany, acquired Nitriflex ABS, Brazil, and SAN, Brazil, the manufacturers of plastic resins, from Nitriflex, Brazil. Terms not disclosed.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">San</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Product Line Not Found</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,686,221,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,659,765,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Nitriflex</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2821 - Plastics materials and resins</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_110"></A><!-- Hide XML section from browser
<DOC NUMBER=111>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">111 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1998 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Nihon Bayer Agrochem Kk</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Nihon Bayer Agrochem Kk</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">January 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 1, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">103897</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 1, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, Germany, the chemicals group, acquired a further stake in Nihon Bayer Agrochem KK, Japan, the manufacturer of crop protection products, increasing its total stake to 95.6%. Terms not disclosed.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Nihon Bayer Agrochem Kk</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Japan</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Product Line Not Found</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,686,221,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,659,765,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Nihon Bayer Agrochem Kk</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Japan</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2879 - Agricultural chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_111"></A><!-- Hide XML section from browser
<DOC NUMBER=112>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">112 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1998 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Sanvet Pty Ltd</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Adcock Ingram Ltd.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">January 1, 1998</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 1, 1998</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">103874</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 1, 1998</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, Leverkusen, Germany, the chemical company, acquired Sanvet (Pty) Ltd, Pretoria, South Africa, the animal health medicine company, from Adcock Ingram Ltd, the healthcare company. Terms not disclosed.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sanvet Pty Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Product Line Not Found</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,686,221,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,659,765,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Adcock Ingram Ltd.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Adcock Ingram Park, 17 Harrison Avenue, Bryanston, Gauteng, 2021</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">S0037E12</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_112"></A><!-- Hide XML section from browser
<DOC NUMBER=113>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">113 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1997 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Florasynth Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Florasynth Inc</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 2, 1997</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 13, 1995</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">June 6, 1995</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">16519</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">June 6, 1995</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG acquired Florasynth Inc. Consideration undisclosed.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Florasynth Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Oils, flavoring materials</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$28,389,126,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,280,435,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Florasynth Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">300 North Street, Teterboro, NJ 07608-1204 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2899 - Chemical preparations, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_113"></A><!-- Hide XML section from browser
<DOC NUMBER=114>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">114 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1997 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Iron Oxide Business</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Landers Segal Color Inc</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 13, 1997</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">October 3, 1996</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">October 3, 1996</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">4761</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture - Assets Acquired</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">October 3, 1996</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">This asset-based acquisition includes the blending, marketing and distribution operations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Iron Oxide Business</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Iron oxide business</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,493,346,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,680,932,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ACCOUNTING FIRMS</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10">&nbsp;</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Name</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">Role</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">C &amp; L Deutsche Revision</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Auditors</SPAN></P>
</TD><TD WIDTH="26.92%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Landers Segal Color Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">84 Dayton Avenue, Passaic, NJ 07055 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2816 - Inorganic pigments</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_114"></A><!-- Hide XML section from browser
<DOC NUMBER=115>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">115 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1997 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Central De Polimeros Da Bahia</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Central De Polimeros Da Bahia</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 1, 1997</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">January 1, 1997</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 1, 1997</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">97725</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 1, 1997</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer, Germany, chemicals group, acquired a 66% stake in Central de Polimeros da Bahia, Brazil, manufacturer of polymers. Consideration $51.6m.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">66.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$53,088,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$53,088,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$53,088,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$53,088,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Central De Polimeros Da Bahia</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miscellaneous Manufacturing</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Product Line Not Found</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,832,252,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,770,213,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Central De Polimeros Da Bahia</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brazil</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">3999 - Manufacturing industries, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_115"></A><!-- Hide XML section from browser
<DOC NUMBER=116>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">116 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1997 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Pharmacia &amp; Upjohn, Inc.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer Corp.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Pharmacia &amp; Upjohn, Inc.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">January 1, 1997</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">January 1, 1997</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">January 1, 1997</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">97368</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">January 1, 1997</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer, Germany, chemicals group, through its subsidiary Bayer Corporation, US, acquired the animal vaccines business of Pharmacia &amp; Upjohn, US, pharmaceuticals group. The deal comprises manufacturing and reseach facilities in Worthington, Minnesota, production site in Omaha, Nebraska and the intellectual property and diagnostic services. Terms not disclosed.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pharmacia &amp; Upjohn, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">New York Stock Exchange</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pharmaceutical Preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,832,252,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,770,213,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pharmacia &amp; Upjohn, Inc.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">7000 Portage Rd, Kalamazoo, MI 49001 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Paul Fitzhenry</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">PNU</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">71708110</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_116"></A><!-- Hide XML section from browser
<DOC NUMBER=117>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">117 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1996 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Blood Plasma Laboratory</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Bayer SpA</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Sclavo Spa</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">July 1, 1996</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">July 1, 1996</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">July 1, 1996</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">94678</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">July 1, 1996</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer SpA, Italy, subsidiary of Bayer AG, Germany, chemicals company, acquired a blood plasma laboratory from Sclavo SpA, Italy, from Gruppo Marcucci, vaccines company. Consideration GB&pound;23.55m (DM55m).</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$36,585,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$36,585,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$36,585,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$36,585,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Blood Plasma Laboratory</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Italy</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pharmaceutical Preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1993</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">66.306</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-15.612</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-15.612</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">12.015</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6.377</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">12/31/1993</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">66.306</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Pretax Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-15.612</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-15.612</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Depreciation / Amortization</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">12.015</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Interest and Expenses</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">6.377</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$42,929,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash and Marketable Securities</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$27,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Long Term Debt</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$24,460,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$4,990,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer SpA</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$31,493,346,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,680,932,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sclavo Spa</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Italy</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_117"></A><!-- Hide XML section from browser
<DOC NUMBER=118>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">118 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1995 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Microbial Developments Ltd</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Microbial Developments Ltd</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">November 1, 1995</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 1, 1995</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 1, 1995</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">90371</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 1, 1995</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, chemicals group, acquired Microbial Developments, biotechnology firm. Consideration more than &pound;12m.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">(CPN: /M DNMJZ) (CPN: /G NA) (CPN: /H NA)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$18,753,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$18,753,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.615</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$18,753,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$18,753,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Microbial Developments Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Development, manufacture and marketing of microbiological products.</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Assets</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$14,944,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$11,800,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">69,300,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Microbial Developments Ltd</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Willow End Farm, Blackmore Park Road, Danemoor Malvern, Worcs, WR13 6NN</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_118"></A><!-- Hide XML section from browser
<DOC NUMBER=119>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">119 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1995 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Printing Plates Business of Hoechst Ag</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Agfa Gevaert AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Hoechst AG</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">November 1, 1995</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">November 1, 1995</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">November 1, 1995</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">90490</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Divestiture</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">November 1, 1995</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agfa-Gevaert, photographic subsidiary of Bayer, Germany, chemicals company, acquired the printing plates business of Hoechst, Germany, fellow chemicals company and the worlds largest producers of offset printing plates, marketed under the Ozasol brand. Consideration DM700m (&pound;252m).</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$393,805,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$393,805,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$393,805,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$393,805,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Printing Plates Business of Hoechst Ag</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Printing &amp; Publishing</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Product Line Not Found</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Agfa Gevaert AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">69,300,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Hoechst AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Brueningstrasse 50, Frankfurt, 65929 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Justus Mische, Chairman</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Division</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">HOEG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">80105N10</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2759 - Commercial printing, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_119"></A><!-- Hide XML section from browser
<DOC NUMBER=120>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">120 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1995 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">Florasynth Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Haarman &amp; Reimer Corp</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">Florasynth Inc</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 1, 1995</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 1, 1995</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">March 1, 1995</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">86818</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Private Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">March 1, 1995</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG, Germany, chemicals group, through its subsidiary Haarmann &amp; Reimer, US, acquired Florasynth Inc, US, manufacturer of fragrances for cosmetics. Terms not disclosed.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Not disclosed</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Florasynth Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Oils, flavoring materials</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Haarman &amp; Reimer Corp</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Sales</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$28,389,126,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Net Income *</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,280,435,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">* Source: Standard &amp; Poors</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Florasynth Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">300 North Street, Teterboro, NJ 07608-1204 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2899 - Chemical preparations, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_120"></A><!-- Hide XML section from browser
<DOC NUMBER=121>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">121 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1994 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">North American Over-The-Counter Business of Sterling</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">North American Over-The-Counter Business of Sterling</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">September 1, 1994</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">September 1, 1994</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">September 1, 1994</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">85177</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of non-US (foreign) company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">September 1, 1994</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miles, US subsidiary of Bayer, is to acquire the North American over-the-counter medicines business of Sterling Winthrop, from SmithKline Beecham. Consideration $1bn (&pound;649m).</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,016,493,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,016,493,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,016,493,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$1,016,493,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">North American Over-The-Counter Business of Sterling</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Product Line Not Found</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">North American Over-The-Counter Business of Sterling</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2833 - Medicinals and botanicals</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
<DIV CLASS="c15">&nbsp;</DIV>
<A NAME="DOC_ID_0_121"></A><!-- Hide XML section from browser
<DOC NUMBER=122>
<DOCFULL> -->
<BR><DIV CLASS="c0"><P CLASS="c1"><SPAN CLASS="c2">122 of 122 DOCUMENTS</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><P CLASS="c1"><SPAN CLASS="c2">Copyright 1994 FactSet Mergerstat, LLC</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c2">Mergerstat M &amp; A Database</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">TARGET:  </SPAN><SPAN CLASS="c2">ChemDesign Corp.</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">BUYER:  </SPAN><SPAN CLASS="c2">Bayer AG / Miles Inc</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">SELLER:  </SPAN><SPAN CLASS="c2">ChemDesign Corp.</SPAN></P>
</DIV>
<BR><DIV CLASS="c3"><BR><P CLASS="c1"><SPAN CLASS="c4">LAST UPDATE:  </SPAN><SPAN CLASS="c2">March 18, 1994</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">ANNOUNCE DATE:  </SPAN><SPAN CLASS="c2">March 11, 1994</SPAN><SPAN CLASS="c2">&nbsp;</SPAN><BR><SPAN CLASS="c4">EFFECTIVE DATE:  </SPAN><SPAN CLASS="c2">April 8, 1994</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><BR><P CLASS="c6"><SPAN CLASS="c4">DEAL NO.:  </SPAN><SPAN CLASS="c2">13216</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * TRANSACTION SUMMARY * * * * * * * * * * * * * *</SPAN><BR><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition Tender Offer</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Acquisition of Public Company</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Purpose:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Horizontal</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Date:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">April 8, 1994</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Attitude:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Neutral</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Source of Funds:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Deal Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG through Miles Inc. acquired ChemDesign Corp. Consideration $76.35M.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Transaction Notes:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">(Src Fix-It: COMBO)</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Premium Offered:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">0.332</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Percent Sought:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">100.000%</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$8.500</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Original Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$76,350,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Closing Offer Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$76,350,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Price/Earnings:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">44.737</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Multiple of Book Value:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.463</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Terms:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Available</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Method of Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Combo</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cash Payment:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$-1,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other Payments:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$-1,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Total Invested Capital:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$105,000,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Base Equity Price:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$76,350,000</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * TARGET DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ChemDesign Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Country:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Over the Counter</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Chemicals, Paints &amp; Coatings</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Manufactures organic chemicals for the agricultural, reprographic, photographic and advanced materials industry</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">ANNUAL RESULTS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">10K</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">06/11/1993</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">44.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">LATEST TWELVE MONTHS</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">SEC Filing</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">Other</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">(Millions US $)</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c4">06/11/1993</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
<TR><TD WIDTH="48.0%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Revenue</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">44.000</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12"><P CLASS="c13"><SPAN CLASS="c2">-</SPAN></P>
</TD><TD WIDTH="17.33%" CLASS="c12">&nbsp;</TD></TR>
</TABLE>
<DIV CLASS="c5"><BR></DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c4">FINANCIAL SUMMARY:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10">&nbsp;</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Book Value Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$5.810</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Current Shares Outstanding</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">8,982,000</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Earnings Per Share</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$0.190</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 30 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6.630</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Share Price 5 Days Prior</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">$6.380</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * * BUYER DETAILS * * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Bayer AG</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Cross-Reference:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Miles Inc</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werk Leverkusen, Leverkusen, 51368 Germany</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">49.214.30.1</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Contacts:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Werner Wenning, Investor Relations Manager</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Legal Status:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Private</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Products:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Provides a variety of products in areas from health care, agriculture, plastics, and chemicals</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary Industry:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Drugs, Medical Supplies &amp; Equipment</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2834 - Pharmaceutical preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Secondary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2844 - Toilet preparations</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Exchange:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Other</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">BAY</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">07273030</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Description:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Listed Frankfurt SE - BAYG.</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">* * * * * * * * * * * * * * * SELLER DETAILS * * * * * * * * * * * * * * *</SPAN><BR><BR></P>
</DIV>
<TABLE CLASS="c7">
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Name:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">ChemDesign Corp.</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Address:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">99 Development Road, Fitchburg, MA 01420 United States</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Telephone Number:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">1.978.345.9999</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Company Type:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Public</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Ticker:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CDCC</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">CUSIP:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">16359410</SPAN></P>
</TD></TR>
<TR><TD WIDTH="46.15%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">Primary SIC:</SPAN></P>
</TD><TD WIDTH="53.85%" CLASS="c10"><P CLASS="c6"><SPAN CLASS="c2">2819 - Industrial inorganic chemicals, nec</SPAN></P>
</TD></TR>
</TABLE>
<DIV CLASS="c5"></DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">PUBLICATION-TYPE: </SPAN><SPAN CLASS="c2">Mergers and Acquisitions Reports</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LANGUAGE: </SPAN><SPAN CLASS="c2">ENGLISH</SPAN></P>
</DIV>
<BR><DIV CLASS="c5"><P CLASS="c6"><SPAN CLASS="c4">LOAD-DATE: </SPAN><SPAN CLASS="c2">June 14, 2005</SPAN></P>
</DIV>
<!-- Hide XML section from browser
</DOCFULL>
</DOC> -->
</BODY></HTML>